Board of Directors - Basildon and Thurrock University Hospitals
Transcription
Board of Directors - Basildon and Thurrock University Hospitals
Board of Directors agenda Date 24 November 2010 Time 1:00pm Place Training Rooms B2/3 Postgraduate Education Centre Basildon University Hospital Contact Angus Wyatt Basildon and Thurrock University Hospitals NHS Foundation Trust Nethermayne Basildon Essex SS16 5NL Tel: 0845 155 3111 Extension 3874 Email: Angus.wyatt@btuh.nhs.uk 1 Members of the Board of Directors Chairman Mr M Large Non Executive Directors Mrs J Gibson Mr R Holmes Mr J Kent Mr T Parks Mr P Sheldrake Ms H Sturgess Mr P Wardle Executive Directors Mr A R Whittle Mrs J Galpin Mr M Magrath Dr S Morgan Mr A Ray Mrs D Sarkar Mr A Sewell-Jones Mr N Taylor Chief Executive Director of Estates and Facilities Director of Operations and Service Development Medical Director Acting Director of Finance (non voting member) Director of Nursing Programme Director and Director of Continuous Improvement Director of Personnel and Organisational Development Quorum No business shall be transacted at a meeting of the Board of Directors unless at least five Directors including not less than two executive and not less than two nonexecutive Directors are present. 2 PART ONE – PUBLIC MEETING AGENDA Item No Page No The meeting will be preceded by a Clinical Presentation on Organ Donation – Dr Amin Darwish 5 SECTION 1 – Administration (1) 1 (1) 2 (1) 3 (1) 4 Chairman’s Welcome and Note of Apologies for Absence Minutes of the Meeting held on 27 October 2010 Matters Arising from the Minutes of the Meeting held on 27 October 2010 Evaluation of the Meeting held on 27 October 2010 7 15 SECTION 2 - Operational Performance (2) 5 (2) 6 (2) 7 Performance Report for October 2010 Report from the Programme Management Office and KPI Schedule Items considered by the Board of Clinical Directors 17 66 77 SECTION 3 – Contemporary Reports from Executive Directors (3) 8 Chief Executive Verbal report (3) 9 Chairman Verbal report (3) 10 Joint Report of the Director of Nursing and Medical Director Quality innovation and Patient Safety Strategy (Presentation) (3) 11 Director of Personnel and Organisational Development Health and Safety Improvement Notices – Verbal report (3) 12 Corporate Secretary CQC Provider Compliance Review Notification 79 SECTION 4 – Reports on Committee meetings since 28 July 2010 (4) 13 Clinical Governance Committee (15 November 2010 - verbal) SECTION 5 – Reports for Information None 3 SECTION 6 – Regulatory Matters – Report from Corporate Secretary (6) 14 Compliance with CQC Conditions 81 SECTION 7 – (7) 15 Questions from Governors - to respond to written questions from Governors (7) 16 Public Questions - to respond to written questions from members of the public (7) 17 Use of the Corporate Seal - to note the occasions on which the Corporate Seal has been used since the last meeting (7) 18 Date, Time and Venue of next Meeting The next meeting is scheduled for Wednesday 22 December, at 1:00pm, in Rooms B2/B3, Education Centre, Basildon Hospital (7) 19 Any Other Business Exclusion of the Press and Public: To Resolve “That representatives of the Press and other Members of the Public be excluded from the remainder of this meeting, having regard to the confidential nature of the business to be transacted, publicity on which would be prejudicial to the Public Interest” (Section 1(2) Public Bodies (Admission to Meetings) Act 1960) 4 BOARD OF DIRECTORS MEETING: 24th NOVEMBER 2010 REPORT RE WORK OF THE ORGAN DONATION COMMITTEE BACKGROUND ¾ The main findings of the Organ Donation Taskforce were around the widening gap between the need for organs and their supply, and how the UK rates of donation are seen to be amongst the lowest of any developed nation. ¾ August 2008 - the then Secretary of State determined that Chief Executives and Medical Directors are to be accountable to their Boards for “donation performance”. Progress has to be reported periodically to Executive Boards. ¾ National roll out programme with the formation of Donation Committees and the prescribed aim of “making donation usual, NOT unusual”; linked to a countrywide target to increase the level of donations by 50% within a 5 year period. ¾ Programme required the appointment of Hospital-based Clinical Leads (“CLODs”); working in association with local Lay Chairmen (“DCCs”) ¾ Programme is resourced via NHS Blood and Transplant (“NHSBT”) with additional funds paid to Hospitals, including money for Committee expenses and financial “rewards” for providing organs for donation. ¾ Programme provides for the appointment of additional Donor Transplant Coordinators (“DTCs” / ”SNODs”) and an expansion of their role, including the support of more retrieval teams. ¾ National Launch Event was followed by a programme of personal development for CLODs and DCCs. ¾ Some Hospitals yet to form Committees or to identify a suitable Lay Chairman. ¾ The ”Six Big Wins” to focus on are: o increased rates of consent/ authorisation, o increased diagnosis of brain-stem death, o increased donation after cardiac death, o increased rates of donation in Emergency Medicine, o increased rates of referral, o increased quality & quantity of organs through improved donor management. BTUH ¾ Appointments o Summer 2009 - Dr Amin Darwish appointed as CLOD o February 2010 - Neville A. Brown JP nominated as DCC o By late Spring 2011 - our DTC Hannah Perry will have been trained by NHS BT and will be resident in the hospital ¾ BTUH OD Committee met in March, May and September 2010 ¾ The presentation by Dr Darwish will : o help explain aspects of the “Six Big Wins” o outline the main local challenges connected with this programme o report progress with “engagement” of a range of colleagues across BTUH o provide some relevant statistics o outline what may feature in the BTUH Organ Donor Annual Plan (to be discussed at our next Committee meeting in December 2010; date tbc) NAB/AD 101117 5 This page is left blank intentionally 6 BOARD OF DIRECTORS MINUTES OF THE MEETING HELD ON WEDNESDAY 27th OCTOBER 2010 PART 1 Present:Non Executive Directors: Executive Directors: Mr M Large Mrs J Gibson Mr R Holmes Mr J Kent Mr T Parks Mr P Sheldrake Ms H Sturgess Chairman Mr A Whittle Mrs J Galpin Mr M Magrath Dr S Morgan Mrs D Sarkar Mr A Ray Chief Executive Director of Estates and Facilities Director of Operations and Service Development Medical Director Director of Nursing Acting Director of Finance (non-voting member) Mrs S Lawton Ms A Saville Mrs R Taylor Mrs P Trinnaman Mr A Wyatt Mr G Mummery Sharna Mrs N Laver Mr J Austin (for Mr N Taylor) Corporate Secretary (for Mr A Sewell-Jones) Associate Director – Communications Board Secretary Staff Staff Communications Evening Echo In Attendance: Governors in Attendance: Neville J Brown JP Ms B Hallows Mr D Sydney Mr T Hubbard 116/10 APOLOGIES Apologies for absence were received from Mr A Sewell-Jones (Programme Director and Director of Continuous Improvement), Mr N Taylor (Director of Personnel and Organisational Development) and Mr P Wardle (Non Executive Director). 117/10 MINUTES The minutes of the Part 1 meeting held on 29th September 2010 were approved as a correct record and signed by the Chairman subject to the amendment of Minute 106/10 to amend the title to read: “Report of the Acting Director of Finance”. 118/10 MATTERS ARISING 7 The Board satisfied itself that all necessary action had been taken in relation to the action log appended to the minutes. 119/10 EVALUATION OF THE MEETING HELD ON 29th SEPTEMBER 2010 The Board noted the detail of the evaluation of the Board of Directors Meeting held on 29th September 2010. 120/10 PERFORMANCE REPORT FOR SEPTEMBER 2010 The Board considered the performance report for September 2010 against the key themes of Patient Safety, Patient Experience, Efficiency and Effectiveness and Look and Feel. During discussion the following points were noted:• The Trust’s rebased 12 month rolling average HSMR had been recorded at 98.3. The Trust’s performance for the first quarter was recorded at 88. • The Board was advised by the Director of Nursing that the Trust had now established a group whose main focus was to consider further, the Trust’s patient fall performance with a view to improving it going forward and a robust action plan had been developed • The Trust had now introduced measures to improve compliance with achieving the MRSA Emergency Admissions Screening performance. • All waiting time standards had been achieved within the month with the exception of the 62 day cancer screening to treatment target where the Trust had recorded 2.5 breaches against a total volume of 9 patients during Q2. The pathways of the 3 patients that breached 62 days had been reported to the Finance and Performance Committee and related to patient initiated delays in diagnoses and complex care pathways. • The Trust’s performance in relation to the access standard for A&E had seen the Trust recorded as 4th best performer in the Country. • Feedback from the Patient Tracker system and the continued high performance against the question “would you recommend this hospital?”, recording 96% satisfaction against this question. • The Board was advised of the Trust’s performance in relation to DSSA breaches and noted that the Trust supplied monthly reports to the Primary Care Trust. It was considered useful for this detail to be included in the Performance Report going forward. Action 1: Directorof Operations and Service Development • The Trust recorded a net Income and Expenditure position of a £0.2m deficit in September with a £0.6m deficit for the year to date. The full year forecast had deteriorated to reflect a £1m deficit at year end. • The Trust delivered £5.9m of cost improvements, against a plan of £7.1m. A financial recovery plan has been instigated and discussed in detail at both the Finance and Performance Committee and Board of Clinical Directors. The Board noted the success in the control of pay budgets related to a decrease in the use of Agency staff, with a subsequent increase in the use of Bank staff. 8 • The Finance and Performance Committee had received a presentation from the Management team of the Essex Cardiothoracic Centre in relation to its proposals to return to planned activity levels for the remainder of the financial year. 121/10 REPORT OF THE PROGRAMME MANAGEMENT OFFICE AND KPI SCHEDULE The Board considered the report of the Programme Director and Director of Continuous Improvement which presented an update on the progress and achievements of the projects overseen by the Programme Management Office since the last meeting. The Board noted the summary key issues which included: • The PMO was currently overseeing 30 projects. • There were 2 projects in the pipeline. • Of the 1,165 milestones (or actions) that were due for completion since the start of the programme, 26 were outstanding (2%). • At the current time there were 42 key performance indicators (KPIs) being monitored by the Programme Board and of these, 18 or 43% were not being fully met. • One project (A&E Improvement) was currently temporarily suspended from the programme pending major revision to the projects and was therefore not currently being measured. 122/10 ITEMS CONSIDERED BY THE BOARD OF CLINICAL DIRECTORS The Board noted the report of the Chief Executive which presented the list of items considered by the Board of Clinical Directors since the last Board of Directors meeting. The Chief Executive advised the Board that the Trust’s A&E performance reflected the success of the Trust in managing its bed capacity. The Board of Clinical Directors had also recently considered the financial recovery plan. 123/10 REPORT OF THE CHIEF EXECUTIVE The Board received a verbal report from the Chief Executive which advised on the following matters: Primary Care Trust Turnaround Plan NHS South West Essex Board was due to consider version two of the Primary Care Trust turnaround plan at its meeting today. The Primary Care Trust plan was, so far, broadly on target and it was recognised that the plan would reduce this organisation’s income. Whilst it was noted that the programmes of work proposed by the Primary Care Trust had received a degree of support from this Trust, the pace of change within the plan remained a challenge for all those involved. The Trust continued to meet with the Primary Care Trust. Following a question from Mr T Parks, the Board was advised that the Trust had responded robustly to Primary Care Trust proposals to delay the treatment of patients. It was however recognised that the focus of the Primary Care Trust’s delay in treatment did not relate to patients requiring urgent treatment but related to a planned slow down in elective activity. The Trust had however, reminded the Primary Care Trust that contractual terms were in place covering activity and waiting times. 9 Hospital Open Day The Chief Executive advised the Board of the recent successful Open Day, where the Trust had welcomed approximately 800 members of the public. There had been good media coverage of the day. HSMR The Board was advised that Dr Foster was due to publish its Good Hospital Guide, although the Trust had not received early sight of the detail to be published in the guide. Healthcare Financial Management Association The Board was pleased to note the Trust had two short listed entries for awards from the Healthcare Financial Management Association. Mr A Ray had been nominated for Deputy Director of Finance of the year and his team’s work in improving efficiency and establishing ward based metrics had seen their nomination for an award also. 124/10 REPORT OF THE CHAIRMAN The Board received a verbal report from the Trust Chairman which advised on the following matters: Trust Open Day The Chairman echoed the sentiments of the Chief Executive in that the recent Trust Open Day had been a tremendous success. The turnout had been good with a number of visitors remarking that they had been impressed with the quality of the facilities and services provided by the Trust. Appointments The Chairman advised the Board of the recent appointment of Hannah Coffey as Director of Operations, who was due to start her employment with the Trust in the New Year. The Board was also pleased to note the appointment of Mrs Diane Sarkar to the substantive position of Director of Nursing. The Board of Governors was in the process of considering appointments to the positions of Trust Chairman and 3 Non Executive Directors. East of England Innovations Council The Chairman advised the Board of the Trust’s intention to pursue and maintain its good performance in relation to awards for innovation from the East of England Innovations Council. 125/10 REPORTS ON COMMITTEE MEETINGS SINCE 29th SEPTEMBER 2010 Clinical Governance Committee The Board received a verbal update from the Chair of the Clinical Governance Committee advising of the matters which had been considered at the Clinical Governance Committee Meeting held on 11th October 2010. The Committee continued to monitor the Trust’s ongoing performance in the lead up to the NHSLA Risk Management Standard assessments which were scheduled for General and Maternity Services. 10 The Committee had also considered in detail, revisions to Trust processes in relation to the management of complaints and the investigation process related to serious incidents. The Committee had discussed in detail the new quality strategy which was due to be published imminently. The Committee had also trialled patient stories. The Committee had also received a quarterly report on Corporate Clinical Audit. Finance and Performance Committee The Board received a verbal report from the Chair of the Finance and Performance Committee in relation to those matters considered at the Finance and Performance Committee Meeting held on 25th October 2010. The Committee had considered in detail the six monthly results for financial performance and had discussed and agreed the Monitor Q2 return on behalf of the Board. The recent Care Quality Commission visit had also been discussed. The Committee had also received reports from the management teams of the Essex Cardiothoracic Centre and Obstetrics and Gynaecology Directorate in relation to their service line reporting performance for the year to date and going forward. The Board was reminded that the maternity direct initiative had been extremely popular following its introduction earlier in the year with over 1000 contacts for the year to date. 126/10 REGULATORY MATTERS The Board noted the report of the Corporate Secretary which informed the Board on progress with the action plans developed to ensure compliance with the conditions to the Trust’s registration with the Care Quality Commission. Contact with Regulators The Board noted the report of the Corporate Secretary which provided a summary of contacts with Regulators and external agencies between 29th September 2010 and 20th October 2010. 127/10 QUESTIONS FROM GOVERNORS There were no questions from Governors. 128/10 PUBLIC QUESTIONS There were no public questions. 129/10 USE OF THE CORPORATE SEAL It was noted that the Corporate Seal had not been used since the last meeting. 130/10 DATE, TIME AND VENUE OF NEXT MEETING The Board was advised that the next Part 1 meeting was scheduled for Wednesday 24th November at the earlier time of 1:30 pm in Rooms B2/3, Education Centre, Basildon Hospital. 131/10 ANY OTHER BUSINESS There were no other items of business. 11 Signed ………………………………………………… (Chairman) Date………………………..…………………………… 12 BOARD OF DIRECTORS (PART 1) MEETING 2010 ACTION LOG - PUBLIC Minute Ref and subject Action No Action required Action Owner Date raised Date Due and Report to Action Status/ Progress Outcome/ Impact for patients (date action Agreed) 120/10 Performance Report 1 Include DSSA breach information in monthly performance report to the Board 27 Director of October Operations 2010 and Service Development 24 November 2010 BoD 13 This page is left blank intentionally 14 Evaluation of Board of Directors’ meeting held on 27 October 2010 27-Oct-10 ORGANISATION The meeting agenda was effectively organised. 4.6 You had sufficient time in advance of the meeting to review Board materials. 4.6 Background material provided was adequate to make informed decisions. 4.4 The source of data was known and was complete and accurate. 4.5 AGENDA The meeting discussions were valuable and focused. AVERAGE SCORE The meeting agenda included relevant topics and focused on key priorities. The impact on quality was given appropriate consideration in the making of decisions. 4.3 4.5 4.6 PARTICIPATION Robust discussion and debate of proposals took place prior to decisions being made. Board members are encouraged to and feel free to participate in the meeting. 4.4 4.7 Your time was well spent participating in this meeting. 4.7 Board members clearly understand the aims of the Trust and role of the Board. 4.6 CHAIRMANSHIP The chairman ensured that actions were assigned and executive directors were held to account for delivery. The extent of the chairman’s own contribution allowed executive directors were held to account for their own areas of responsibility. 4.8 4.8 15 Evaluation of Board of Directors’ meeting held on 27 October 2010 Much better time management, especially on Performance Report. Good Agenda, which benefitted from being lighter than more recent meetings. Excellent input and challenge from the deputy directors Good succinct Well paced. Good debate High use of abbreviations/ acronyms which are not explained Presentation of the Performance report was improved It was a relatively light agenda. I don’t know whether this contributed to the relatively low attendance from Governors. Comments Overall evaluation of the meeting Focused discussion and debate. Short agenda this month I thought that the Performance Report seemed to have been developed so it was clearer and discussion focused on key changes –good or bad with explanation/clarification if required. I have felt in the past that it was a bit like an account and this ‘exception reporting‘ with questions is so much better. I did not get a handle on the verbal report for clinical governance-possibly it was me? Verbal reports still need to be clear and factual. The Chairman usually makes a short statement/point after these so that helps but not on that one. I tend to watch and listen as there is not time to read all the papers and left with most of my questions answered and an overall confident and positive feel good factor-thanks. The venue was changed and no ‘alert’ was sent to inform governors Comments Suggestions for future meetings Other Comments Agree that timing changes are sensible. We still need to look at acoustics / PA system Large and important documents requiring a decision should not be tabled Discussion on Quality Strategy and Serious Incidents would have been better with papers in advance of the meeting 16 Performance Report October 2010 Board of Directors November 2010 17 Section A: Performance Dashboard – October 2010 Patient Safety Previous month RAG Hospital Standardised Mortality Ratio (HSMR) Hospital Acquired MRSA bacteraemia Hospital Acquired Clostridium difficile episodes Hospital acquired pressure ulcers Patient falls 98.3 2 23 6 832 12 mth YTD YTD In mth YTD Efficiency and Effectiveness RAG Monitor Financial Risk Rating Cost Improvement Plan surplus/(deficit) % of relevant staff with documented appraisals Vacancy factor Sickness absence YTD YTD 12 mth In mth % In mth % 99.9 2 20 11 683 Previous month 3 3 (£1,589k) (£1,040k) 73 71 8.2 9.25 3.06 2.98 Patient Experience Previous month RAG < 18 wks referral to treatment (admitted) < 18 wks referral to treatment (non‐admitted) A&E 4hr to admission or discharge All cancer targets being met Overall satisfaction score (Patient Tracker) In mth % In mth % In mth % In mth In mth % 91.4 96.5 99.1 5 of 7 88 90.5 96.5 98.0 6 of 7 89 Would you recommend this hospital? (Patient Tracker) In mth % 96 97 Look and Feel Previous month RAG Cleaning scores ‐ Very High Risk Areas Cleaning scores ‐ High Risk Areas Statutory maintenance completed Water systems maintenance completed Planned preventative maintenance completed In mth % In mth % In mth % In mth % In mth % 98 96 90 95 93 18 98 97 89 96 80 Section B: Executive Summary Patient Safety Measures to improve Patient Safety in 2010/11 will continue to include the effectiveness of actions to reduce Inpatient Falls, Medication Incidents and Pressure Ulcers. An observational audit to assess compliance with the World Health Organisation (WHO) Surgical Checklist has been planned for the fourth quarter of the year. National Patient Safety Week occurs from 15‐21 November 2010. The Trust has registered to participate in this event, many of the arrangements will be similar to last year, along with accompanied Executive walkabouts, the Patient Safety Team will man a patient safety awareness stand within the hospital main reception featuring changing topic throughout the week. This report has provided an update on Serious Incidents (SIs). Only 53% of emergency patients were screened for MRSA in September, which is down from September (60%) and August (69%). The Director of Nursing has requested action plans from all Directorates. A verbal update will be provided at the Board. Patient Experience The number of complaints has increased slightly with 41 received in October (39 in September). There are no identifiable trends developing, however “every aspect of medical care/treatment” continues to be the primary theme, with a high number this month (9) being received in the Accident and Emergency Department (the same number was received last month). Directorates are looking at strategies to provide local analysis of these figures. The overall Patient Tracker satisfaction score was 88%. The number of responses again exceeded the monthly target (3,500) with 3,721 in October, a slight decrease on September (3,886). The number of formal plaudits (acknowledged by the Chief Executive) significantly increased with 32 received in October (17 in September). The collated number of plaudits, which includes those received via the “Get It Right” comment cards, PALS contacts, NHS Choices and written expressions of appreciation directly to the wards, increased to 152 (145 reported in September). The A&E and 18 week targets were achieved in October. However, the 62 day cancer screening to treatment target and 2 week wait target were not achieved in the month – Section D provides a full explanation. Achievement of the 18 week admitted target in future months remains at risk due to a high backlog of patients waiting over 18 weeks for admission, as also explained in Section D. 19 Section B: Executive Summary Efficiency and Effectiveness The Trust has a £0.7m cumulative net deficit for the seven months to the end of October, with October being break‐ even in the month. The year‐end forecast is maintained at a £1m deficit, but the internal target is still a £1m surplus. The current FRR is 3, as assessed by Monitor. The forecast for the year‐end is a FRR of 3. There is an increased risk to the forecast due to the PCT Turnaround plan, which potentially could increase the deficit. The net deficit would have to be greater than £4.3m to not achieve a FRR of 3. The Trust has delivered a £6.8m CIP to date against a plan of £8.4m. New schemes have been added to meet the shortfall. Pay Expenditure continues to be lower than last year, this is a result of successful management action to reduce agency and increase bank usage. October saw a reduction in the use of Medical Agency staffing. The CTC Directorate activity recovery plan has seen an improvement in income of £0.2m in October. A Financial Recovery Plan has been instigated to ensure achievement of the financial targets. This plan was presented to and agreed by the Board of Clinical Directors in October. Compliance with appraisals within the Trust has already exceeded target, with 77% of staff being recorded as having had an appraisal as at October. Sickness absence continues to be at a relatively low rate (3.68% for the 12 months including October). Vacancies have reduced to 8.35% with nursing and midwifery vacancies now being below the Trust‐wide figure." Look and Feel Delivery of the capital programme is progressing. During October the first phase of the Accident and Emergency Department and Fracture Clinic project was handed over to the Trust and became operational. The new offices have been occupied by the Orthopaedic Consultants, their secretaries and the A&E management team. The new minors department was opened in October in line with the project programme. A temporary children’s A&E was also opened in space that will eventually become part of the extended minors department. The permanent children’s department will not be completed until towards the end of the project in 2012. Cleaning scores have been maintained at or above the target level. During October there was one occasion when the cleaning score was reported to be below the Trust trigger point of 96% for very high risk areas and 93% for high risk areas. The Trust achieved its stretch targets of average scores of 98% and 95% respectively in the month. Work commenced in October on the refurbishment of the restaurant to support the introduction of a steam cuisine style food service for patients. This work will take place on a phased basis to allow the Trust to continue to serve food in 20 the restaurant during the period of the works. Section C: Patient safety ‐ Mortality • The 12 month rolling average for the period September 2009– August 2010 is 97.3 • The combined HSMR for the period April – August 2010 is 87. • The in month HSMR for August is 88.7. • The HSMR for the original top 5 HRGs are all within expected limits and the Trust HSMR value has been within expected limits for the last 5 quarters (data source: EoE Quality Observatory) 21 Source of data: Dr Foster Intelligence Section C: Patient safety – Mortality Comparison data Chart A • In April 2010, Dr Foster added additional functionality to the mortality system which enables trusts to “re‐base” their HSMR data. Whilst this is not wholly accurate, it does show estimated performance in relation to other trusts. • Chart A shows the HSMR trend over recent years up to August 2010 as of 1 November 2010. • Chart B shows the relative position of the Trust following re‐basing for the first 5 months of the year (blue dot) The grey dots in the funnel represent all other acute trusts. • The current HSMR for the period April – August 2010 is 87. Chart B 22 Data source: Dr Foster Intelligence HSMR Comparison Report as of 01/11/2010 Month Trust Total Absolute No. of Deaths Discharges % of Trust Absolute Rolling 12 months HSMR 09/10 Trajectory Rolling Deaths (Basket of 56) HSMR (Basket of 56) Jul-07 110 5500 2.0% 137.2 Aug-07 111 5412 2.1% 136.6 Sep-07 138 5252 2.6% 137.7 Oct-07 131 5723 2.3% 137.1 Nov-07 138 5689 2.4% 135.6 Dec-07 167 5197 3.2% 137.5 Jan-08 168 5605 3.0% 136.4 Feb-08 155 5353 2.9% 136.4 Mar-08 182 5408 3.4% 136.3 Apr-08 142 5881 2.4% 136.8 May-08 163 5717 2.9% 139.1 Jun-08 139 5732 2.4% 141.4 Jul-08 121 6071 2.0% 140.4 Aug-08 110 5525 2.0% 140.1 Sep-08 106 5622 1.9% 139.0 Oct-08 142 5781 2.5% 139.2 Nov-08 139 5568 2.5% 139.3 Dec-08 155 5484 2.8% 136.6 Jan-09 192 5809 3.3% 136.5 Feb-09 145 5563 2.6% 135.0 Mar-09 143 6218 2.3% 133.0 Apr-09 126 5687 2.2% 129.3 May-09 114 5599 2.0% 124.3 Jun-09 140 5885 2.4% 122.5 119 119 The number of actual deaths in hospital continues to decrease. Whilst this could be concluded to coincide with seasonal variation, it should be noted that the period April – September 2010 saw a 4.5% reduction in the number of deaths in hospital when compared to same period in 2009. 119 116 Jul-09 100 6151 1.6% 120.1 Aug-09 100 5338 1.9% 118.6 108 113 Sep-09 142 6006 2.4% 117.5 Oct-09 131 6358 2.1% 114.3 116 120 Nov-09 138 6043 2.3% 110.9 Dec-09 119 5791 2.1% 107.8 115 117 Jan-10 173 5466 3.2% 105.6 Feb-10 136 5400 2.5% 102.5 Mar-10 Apr-10 134 139 6411 5780 2.1% 2.4% 115 Source of Data: 100 Dr Foster 106 HSMR monthly trend (August 2009 – August 2010) 97.7 104.3 103 May-10 108 6026 1.8% 103.4 Jun-10 103 6157 1.7% 99.9 99 105 Jul-10 101 6176 1.6% 98.3 Aug-10 113 5927 1.9% 97.4 101 98 Sep-10 125 6065 2.1% Trust Actual Deaths*: AQUIP/MD_DEATHS_1 Discharges: Ardentia/md_spells_drfoster 23 Section C: Patient safety ‐ Infection control In October there were 6 cases of hospital acquired C. Diff. Year to date, the Trust has had 29 cases against a ceiling of 42. Cumulative C‐Diff Performance Trajectory 2009/10 Cumulative C‐Diff A p r ‐1 0 M a y ‐1 0 Ju n ‐1 0 J u l‐ 1 0 A u g ‐1 0 S ep ‐1 0 O c t‐ 1 0 N o v ‐1 0 D ec ‐1 0 Ja n ‐1 1 F eb ‐1 1 M a r ‐1 1 Incentive trajectory MRSA Bacteraemia 5 4 Cumulative MRSA Bacteraemia 3 2 Performance Trajectory 1 A p r ‐1 0 M ay ‐1 0 J u n ‐1 0 J u l ‐1 0 A u g ‐1 0 S e p ‐1 0 O c t ‐1 0 N o v ‐1 0 D e c ‐1 0 J a n ‐1 1 F e b ‐1 1 M a r ‐1 1 ‐ Data source for HCAI: Laboratory results. 2009/10 Cumulative MRSA Bacteraemia The performance ceiling trajectory for MRSA bacteraemia for 2010/11 is 4 hospital acquired cases per year, equating to one per quarter. In October there were no new cases, the total for the year to date therefore remains at 2. Hand Hygiene scores , as observed by patients, achieved 90%. The ambition is to achieve the levels of compliance realised at the end of the 2009/10. The Trust also monitors compliance with hand hygiene standards through the Saving Lives audits, which for September, indicates an overall compliance of 98%. MRSA screening of emergency patients continues within A&E and the admission units. Only 53% of emergency patients were screened for MRSA in October, which is down from September (60%) and August (69%). The Director of Nursing has requested action plans from all Directorates by 24 November 2010. 100% 95% 2009/10 90% 2010/11 Standard 85% 80% 75% Apr M ay Ju n Ju l Aug Sep O ct Nov D ec Ja n Feb M ar 90 80 70 60 50 40 30 20 10 ‐ Hand Hygiene (data source: Dr Foster Intelligence PET 3.0) MRSA Emergency Admission Screening 100% 90% 80% 70% 60% 50% M RSA Emergency Admission Screening Performance Improvement Trajectory A p r ‐1 0 M a y ‐1 0 Ju n ‐1 0 Ju l‐1 0 A u g ‐1 0 S e p ‐1 0 O c t‐1 0 N o v ‐1 0 D e c ‐1 0 Clostridium Difficile 24 MRSA screening for elective admissions has been a national requirement since April 2009 with the aim of reducing the burden of MRSA in the community. Whilst this Trust has been compliant with this requirement, the system for screening has recently changed to ensure full capture of all day case patients. The information is Source of data: Laboratory results reported monthly to the PCT and is monitored through the quality contract monitoring meetings. Section C: Patient safety – Patient Falls Inpatient Falls (data source: Incident Reporting on Ulysses Safeguard System) 1,800 1,600 1,400 1,200 1,000 800 600 400 200 ‐ Cummulative Inpatient Falls Performance Improvement Trajectory Mar‐11 Feb‐11 Jan‐11 Dec‐10 Nov‐10 Oct‐10 Sep‐10 Aug‐10 Jul‐10 Jun‐10 May‐10 Apr‐10 2009/10 Cumulative Patient falls The Falls Group categorise falls into three areas: • Mobility • Clinical • Slips and Trips There was a reduction in the number of falls with 139 inpatient falls reported in October, affecting 110 patients. (149 falls in September affecting 114 patients). There was a small rise in the number of “mobility” falls (41 in October, 37 in September and 37 in August). Clinical falls were slightly reduced with 7 in October (8 in September). Slips and Trips have fallen significantly with 91 in October (104 in September). Many of the falls were not witnessed by staff.. The number of falls for the year to date (April‐October) was 971 which is 9.4% above the trajectory of 880. The majority of incidents relate to patients who experience a first fall and then no other. Even with robust assessment, it is not always possible to predict these events. The Lead of the Falls Group has developed an action plan and this will be discussed during the November meeting. Some of the actions include identifying the cause of the unwitnessed falls. Monitoring the detail of patient falls (see chart below) will help focus on the appropriate actions to reduce 2nd and 3rd falls. There was no RIDDOR reportable falls in October. Patient Falls No. of Patients reported to have 1, 2 and 3+ falls (data source: Incident Reporting on Ulysses Safeguard System) (data source: Incident Reporting on Ulysses Safeguard System) 100 120 80 100 1 Fall 80 Clinical 60 Mobility 40 Slips & Trips 20 60 2 Falls 40 3+ Falls 20 Oct‐1 0 Se p‐1 0 Aug‐1 0 Jul‐1 0 Jun‐1 0 May‐1 0 Oct‐10 Sep‐10 Aug‐10 Jul‐10 Jun‐10 May‐10 Apr‐10 Mar‐10 Feb‐10 Jan‐10 Dec‐09 Nov‐09 ‐ Apr‐1 0 0 25 Section C: Patient safety – Medication Incidents Medication Incidents (data source: Ulysses Safeguard @ 12/11/10) 30 Administration 25 20 Dispensing 15 10 Prescribing 5 0 Apr‐10 May‐ 10 Jun‐10 Jul ‐10 Aug‐ 10 Sep‐10 Oct‐10 Medication Incidents (data source: Incident Reporting on Ullysses Safeguard System) 60 50 40 30 20 10 Mar‐10 Feb‐10 Jan‐10 Dec‐09 Nov‐09 Oct‐09 Sep‐09 Aug‐09 Jul‐09 Jun‐09 May‐09 2010/11 Apr‐09 ‐ •The use of an adapted medication matrix is being considered for medical staff. Nursing and Midwifery staff continue to follow the medication matrix should a medication incident occur. • Current performance indicates a 35% reduction in medication incidents compared to the same period (April – October) in 2009/10. September October Clinical Sciences 0 0 CTC 1 2 Medicine and Emergency Care 7 12 Outpatients 0 0 Surgical Services 5 4 Women & Children’s 5 6 The Safe Handling of Medicines Policy will be reviewed and lessons learnt from previous incidents will be reflected in changes in practice within the updated policy. The frequency of checking Controlled Drug stock levels will be reviewed and new guidance issues. Due to be completed by end of October 2010 The NRLS report for the period October 2009 to March 2010. Presented at the Clinical Governance Management Group (CGMG) in October and an overview provided to the Quality Contract Meeting with NHS South West Essex. The Directorates continue to produce action plans to reduce incidents and improve learning. Ongoing and reported monthly to the CGMG 2009/10 There was an increase in the number of medication incidents reported during October (24) compared to September (18). Whilst there was a downward trend in the number of dispensing incidents with 6 in October (3 in September), the data shows an upward trend in administration incidents. The breakdown of medication incidents by directorate for October, compared to 26 September, is shown in the table to the left. Medicine and Emergency Care reported 12 incidents in October compared to 7 in September. Section C: Patient Safety ‐ Serious Incidents (SIs) There are currently 4 SIs still under investigation. 4 of the incidents reported are now also being reviewed by the Coroner and Legal Department relating to potential claims. T OT AL R E P OR T E D S E R IOU S IN C ID E N T S (Jan u ary to Octo b er 2010) REPORTED SERIOUS INCIDENTS BY CATEGORY January - October 2010 12 withdrawn 3 10 2 8 1 Feb-10 M ar-10 A pr-10 M ay -10 M onthly Total Jun-10 Jul-10 A ug-10 S ep-10 O c t-10 Cum m ulative Total LD PACS Failure Power Outage Theatre Flood Retinal Screening Jan-10 Student Nurse Allegation 0 Maternity Legionella 2 Gynae 0 4 Never Event 6 THEMES AND TRENDS January - October 2010 REPORTED SERIOUS INCIDENTS BY DIRECTORATE January - October 2010 7 5 6 4 5 4 3 3 2 2 1 1 0 0 Women & Childrens Clinical Sciences Surgical Specialties Medicine and Emergency Care Cardiothoracic Centre Estates and Facilities Clinical Care Delivery Issues Impacts on Service Delivery Never Events 27 Trust Reputation Section C: Patient safety – Principles of Care (data source: Audit data compiled by the Clinical Effectiveness Unit) Principles of Care Audit (6 Essential Standards ‐ CQC Conditions) 100% 95% 90% 85% Principles of Care Audit - Trust Totals O c t ‐1 0 S e p ‐1 0 A u g ‐1 0 J u l ‐1 0 J u n ‐1 0 M a y ‐1 0 A p r ‐1 0 M a r ‐1 0 F e b ‐1 0 J a n ‐1 0 D e c ‐0 9 80% • A random sample of 10 healthcare records were audited during October 2010. • To ensure that questions are relevant to appropriate areas, the audit tool was reviewed and refined in relation to the Medical Admissions Unit (MAU) resulting in 9 of the standards assessed as not appropriate to the clinical area. Since the establishment of monthly auditing, the target for each of the standards has been reviewed and 6 standards have been identified as being essential to meet the needs of all patients and to ensure the welfare and safety of the patient. The target will remain at 90%. For the remaining standards, a trajectory has been set in order to achieve the 90% target across all standards by November 2010. • In October the overall average (of all standards) was 92% (93% in August). The improvement trajectory target of 89% was exceeded, with 14 individual standards achieving against their target (between 92%‐99%). For the 6 essential standards, the average performance for October was 96% against the 90% trajectory • There are 14 standards where performance has reduced this month but the majority by only 1 or 2 percent and there are a further 13 standards showing an improvement or are maintaining a consistent performance. Performance Improvement Trajectory Principles of Care Audit Principles of Care Audit (All Standards) (Monthly Result by Directorate) (Total average for all standards) 100% 100% 95% 95% 90% 90% O c t ‐1 0 S e p ‐1 0 A u g ‐1 0 J u l ‐1 0 80% J u n ‐1 0 80% M a y ‐1 0 85% A p r ‐1 0 85% Cardiothoracic Centre Medicine & Emergency Care Oct-10 Total average for all standards Surgical Specialties Women & Children's 28 Performance Improvement Trajectory Performance Improvement Trajectory Source of data: Internal Systems Section C: Patient safety – Pressure Ulcers Pressure Ulcer Incidents per 1000 Occupied Bed Days Pressure Ulcers (data source: Tissue Viability Team & Incident Reports) Grade 2 1.6 1.4 Grade 3 70 1.2 60 Grade 4 50 1 Incidence 0.8 40 Total 30 20 Target 0.6 0.4 10 Patients 0.2 Oct-10 Sep-10 Aug-10 Jul-10 Jun-10 May-10 Apr-10 M ar-10 0 Feb-10 Community Acquired Jan-10 O c t‐1 0 S ep ‐1 0 A u g‐1 0 Ju l‐1 0 Ju n ‐1 0 M ay ‐1 0 A p r ‐1 0 M ar ‐1 0 F eb ‐1 0 Jan ‐1 0 D ec ‐0 9 ‐ The graph (above left) shows the pressure ulcer rates from December 2009. There were 6 hospital acquired pressure ulcers reported in October 2010 (6 in September). The number of patients affected was 6. Performance continues to surpass trajectory. There were 51 community acquired pressure ulcers reported in October, affecting 43 patients. The incidence of pressure ulcers (as shown above right) is calculated as the rate of ulcers per 1000 occupied bed days. As can be seen, there has been a significant reduction from 1.4 per 1000 bed days in January 2010 to 0.31 in October 2010. The Tissue Viability Group is implementing robust systems to ensure shared learning from Root Cause Analysis (RCAs). 29 Section C: Patient safety – Other Vulnerable Patients Safeguarding The Named Nurse for Safeguarding Adults has commenced her review of the arrangements for the management and investigation of safeguarding adult concerns and learning from the outcome of cases. There is a necessity to revise Trust processes to ensure that Clinical Directorates are able to take full ownership of issues that arise through investigations and serious case reviews. Governance arrangements for responding to and learning from incidents is being reviewed and strengthened through more robust monitoring of progress against action plans. This will be via Clinical Directorate reporting mechanisms to the Clinical Governance Management Group and through the Vulnerable People Working Group. Learning Disabilities A regional event was held on 15 November 2011 to launch the strategy ‘Learning Disabilities Vision for the East of England 2011‐2021’. The Trust’s Nurse Advisor for Learning Disabilities has been invited to present the Trust’s Resource File as an exemplar of ‘Innovation and good practice in Acute Hospitals” at this event. A Review of the Trust policy on Caring for people with a Learning Disability, the Specialist Assessment Form (SAF) and the care pathway for people accessing day surgery and dental services. This is was following direct feedback from family carers, Community Learning Disability Teams and following the occurrence of an incident in day surgery. This incident is being managed through the Trust’s Serious Incident Policy. Changes are being made to the policy, SAF form and to the planned care pathway to ensure that sufficient consideration is given to pre‐operative assessment and planning. This will include, where necessary, the option of individual case review by the multidisciplinary team. 2 case reviews have already been carried out, with a third being arranged, at which the team, in discussion with family carers, can plan reasonable adjustments to the care pathway, in particular, those with challenging behaviour. The Trust’s Communication team is working with the Nurse Advisor for LD to develop web based information for patients, carers, staff and the public. It is anticipated that the Learning Disabilities web pages will be launched in the first quarter of 2011. Dementia A Project initiation Document (PiD) has been completed and submitted to the Project Management Office Board for consideration at the meeting being held on the 18 November 2010, highlighting the standards against which the Trust should be able to evidence compliance. The proposed project brings the national dementia strategy, together with the ‘Who Cares’ carers’ project which remains in pilot form on the Trust’s older people’s wards. The Department of Health Strategy for dementia includes direct reference to 30 supporting family carers and the pilot will require Trust wide roll out once formally evaluated by Leeds University later this year. Section C: Patient safety – Emergency preparedness Ensure clear plans are in place to deal with a Flu Pandemic and for business continuity in the event of an unexpected incident or event. Evidenced by successful completion of 2 communication tests and 1 tabletop exercise (or incident) by March 2011. Hospital Incident Control Room. As part of the Trust’s new refurbishment of A&E and the fracture clinic, a dedicated Hospital Incident Control Room has been established. The control room is equipped with up to date technology and can be set up within a short period of time following notification of an incident. The control room will go live early in November. A number of training exercises and scenarios are planned to allow staff and managers to become familiar with the control room environment. Major Incident Plan To coincide with the launch of the new control room a review of the Trust’s major incident plan and staff action cards is being undertaken. Influenza Pandemic Plan The Department of Health has recommended that Health Trusts review their influenza pandemic plans ahead of the publication of the National Framework. The Framework was due out in September but has been delayed. Influenza pandemic plans will now be more generic and expanded to include infectious diseases, surge management, increasing capacity in ITU and dealing with paediatric critical care. Planning for the Unexpected The Trust’s Open Day on Saturday 16th October included details of ‘Planning for the Unexpected’. It provided information to members of the public on how the Trust prepares for an emergency or major incident, but also provided information on how to prepare themselves and their family in case an emergency occurred within the community. Advice included: • Preparing an Emergency Supply Kit • Preparing your home • What to do in an Emergency 31 Section D: Patient experience – Background and context • • • • Measuring patient experience is challenging in that there is no single metric which will provide robust information on all aspects of patient experience. As can be seen from the reports in the following pages, this Trust measures a suite of metrics designed to provide assurance in a number of areas which patients have indicated are important to them. The metrics chosen are centred on a number of themes: – Access to services, including waiting times for cancer and performance against the NHS Constitutional right not to wait longer than 18 weeks to treatment. – Performance against the A&E standard of discharge, transfer or admission within 4 hours of arrival – Privacy and Dignity through compliance with Delivering Single Sex Accommodation standards. – Results of National Patient Surveys with their associated actions. – Content and volume of complaints. – Content and volume of PALS contacts. – Patient Feedback from comments cards, NHS Choices website postings, plaudits and the results from the Dr Foster Patient Experience Tracker. To provide evidence of the aspiration to improve the patient experience score year on year, the Trust strives to achieve the following: No avoidable breaches of the cancer waiting time standards. No avoidable breaches of the 18 week referral to treatment standard. 98% of patients seen and discharged from A&E within 4 hours of arrival. No non clinically justified breaches of the single sex accommodation standard. 70% of complaints responded to within the timeframe agreed with the complainant Over 90% of PALS contacts resolved within 5 working days Over 90% overall satisfaction with the care provided in hospital, with 95% or more of patients stating that they would recommend this hospital to others. 32 Section D: Patient experience ‐ Cancer • October results are provisional and awaiting ratification. • 5 of 7 cancer targets were met in the month (there is no threshold for the 8th). • The 62 day screening was not achieved in October (0.5 breach from 1.5 treatments). The patient that breached 62 days waited 20 days for his first appointment due to a holiday. The patient was referred to a tertiary centre on day 37 of the 62 day pathway and treated at the tertiary centre on day 75. • The 2 week referral target was not achieved in October, but is expected to be achieved in Q3. There were 414 patients seen in October following a 2 week referral, and of these 32 chose to wait longer than the offered appointment within 2 weeks. 11 of the 32 were offered appointments that were not at their local hospital and this contributed to patients’ decisions to wait longer than necessary. From the end of October, all patients have been offered appointments at their local hospital. • Source of all data: National Cancer Waiting Times Database. 33 Section D: Patient experience ‐ 18 week access The October admitted position for the Trust is provisionally 91.4%, which is above the 90% threshold. The non admitted position is provisionally 96.5%, above the 95% threshold. Following the cancellation of operations in August and September due to electrical problems, the backlog of patients waiting over 18 weeks increased and has now plateued at about 230. Future deliver of the 18 week admitted target is therefore at risk, as the backlog of patients waiting over 18 weeks has increased from the typical position of 120. Source of all data: Patient Administration System Patients awaiting admission for treatment Waiting time from referral (weeks) >18 17‐18 16‐17 08/08/2010 115 22 23 15/08/2010 115 26 27 22/08/2010 135 29 34 29/08/2010 149 30 37 05/09/2010 152 26 32 12/09/2010 162 35 43 19/09/2010 188 41 52 26/09/2010 197 48 28 03/10/2010 217 28 36 10/10/2010 221 41 36 17/10/2010 223 31 32 24/10/2010 224 29 41 31/10/2010 233 40 28 14‐16 70 78 98 111 126 112 113 107 80 103 103 90 71 34 Section D: Patient experience – A&E • Performance in October increased to 99.15% within 4 hours. Use of escalation beds increased slightly in October to 5.4, compared to 3.7 per day in September. • The revision to the NHS Operating Framework reduced the threshold for this target to 95%. Monitor’s Compliance Framework has been amended to require performance below 95% to be reported. The contract with PCTs still requires 98% performance. – Source of data: Ascribe Symphony A&E System 35 Section D: Patient experience – CQUIN indicators Annual Target 90 Q2 Target 90% 50% TBA TBA Not yet available Not yet available Reduction in Length of Stay as measured by Dr Foster 95 100 Increase in same day admission for elective surgery 95% N/A Measure at M12 94.75% Increase % of smokers at pre‐operative assessment offered to stop smoking services Increase % of women provided with 1:1 care during labour 75% 50% 98% 85% Measure at M12 Reported at Q2 Reported at Q2 98% Increase home birth rates 2.00 1.80 1.75 1.34% Reduce transfer rate from midwife led unit to obstetric ward 30% 37% 40% 22.80% Implement direct access midwifery care TBA TBA Implemented Increase % of low risk patients receiving brain imaging to include MRI or carotid scans within 7 days of referral 95% 50% Not reported 44% 12% 7% 6% 22 24 Reported at Q2 23 Reduction in Hospital Standardised Mortality Ratio % of all adult inpatients who have had a VTE risk assessment on admission to hospital using the national tool Inpatient survey results ‐ Improvement in responsiveness to personal needs. The indicator will be a composite, calculated from 5 survey questions. 90 Financial impact PCT audit 98% £32,000 88% £42,500 Increase % patients receiving thrombolysis within 3 hours of onset Reduce average length of stay in Stroke Unit Q1 Q2 performance performance 88 Not yet available 29% 62.40% 24 The VTE target for Q2 of 50% was achieved with 62.4% of adult inpatients being VTE risk assessed on admission. Validation is currently taking place regarding the % of deliveries recorded as home birth rates. Although performance will increase it is likely to remain under the target for Q2. Lead midwives have been designated to support women in choosing a home birth. There was a significant reduction in the transfer rate from the midwife led unit to the obstetric ward, with Q2 performance lower than the target for the year. There was a significant improvement in the % of low risk patients receiving brain imaging within 7 days of referral as a result of implementing a 5 day dedicated imaging clinic for stroke patients. 36 Section D: Patient experience – Privacy and Dignity Delivering Single Sex Accommodation (DSSA) The national standards in relation to DSSA are that: Patients should not share sleeping, toileting or washing facilities with members of the opposite sex. Patients of one sex should not have to walk through accommodation used by the other sex when not fully clothed. In order to test compliance with this, from 1 August 2010 the PCT require (through the contract) the Trust to undertake a Root Cause Analysis for any breach. The following breaches have been reported with a total loss of income YTD to the Trust of £7,334: Aug‐10 Sep‐10 Oct‐10 Total No of breaches reported Lost income 5 £6,115 1 £1,220 1 Awaiting coding 7 £7,334 37 Section D: Patient experience – Complaints Complaints Received Monthly Comparison 2008/09, 2009/10 & 2010/11 60 50 40 30 20 10 - Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar 2008/09 27 18 19 26 21 19 19 24 17 25 19 34 2009/10 26 36 40 23 15 29 31 32 35 33 53 49 2010/11 38 33 35 44 43 39 41 The downward trend experienced during July and August 2009/10 was in contrast to a significant rise during the same months in 2010/11. This has now consolidated to a consistent increase at up to 20% on the previous year. There were no red rated complaints in October. There were 6 amber rated complaints, of which 3 related to medical care/treatment, 2 to medical judgement/diagnosis and 1 to nursing care/treatment. In each case, collaboration with the Patient Safety Team identified whether the investigation should be managed via the complaints or the Trust’s incident procedures, in line with Trust policy. These complaints are currently under investigation and will be RAG rated on completion. • There were 41 complaints received in October 2010 (39 in September). The primary themes were:‐ – Every aspect of medical care/treatment 20 (48.78%). The three contributing themes being:‐ • Medical care & treatment 10 (24.39%) • Medical judgement & diagnosis 8 (19.51%) • All aspects of clinical treatment 2 (4.87%) – Appointment delay/cancellation 4 (9.75%) – Waiting Times 4 (9.75%) – Discharge/Follow‐up 3 (7.31%) – Others (including Attitude, Communication, Nursing care/treatment, Missing Medical Records, Hotel Services) 10 (24.39%) • General Surgery has experienced a substantial increase in complaints with 9 in October (2 in September). 8 of these related to “Every aspect of medical care/treatment”. This will be brought to the Patient Experience and Complaints Leads (PECL), and Directorate actions will be reported to the Clinical Governance Management Group (CGMG). • General Medicine has experienced an increase with 7 complaints in October (2 in September). A&E remains high at 9 in October (10 in September). • Complaints relating to Nursing Care/Treatment continue to decrease with 3 in October (6 in August, 4 in September). 38 Section D: Patient experience – Complaints Activity The charts below represent the number of complaint responses that have been sent out from the Trust in October 2010. 53 complaint responses were sent and of these 20 (38%) were in target. 33 responses (52%) were sent out of target as follows:‐ • • • • 20 due to the final signing process 7 to quality or timing of reports from Directorates 5 due to delays in Patient Experience Team (PET) 1 due to unavailable medical records. There are actions in place to:‐ • Improve the quality of the response and ownership from the Directorates • Improve administration processes in PET • Streamline the process for final sign off Each of the above elements is reported and monitored monthly at PECL meetings. 11 contacts have been received in October relating to previously investigated complaints where further information or a meeting has been requested. Reasons for Responses sent out of target October 2010 Responses sent during October 2010 3% 15% 20 38% Final signing process Quality or timing of report from Directorate In Target 33 62% Out of Target 21% 61% Delays in Patient Expereince Team Unavailable Medical 39 Records Section D: Patient experience – Patient Advice & Liaison Service (PALS) • PALS received 210 contacts in October 2010 of which 92.9% were responded to in target. The main categories were:‐ Advice 48 (22.85%) Appointment Delay/cancellation OPD 31 (14.76%) Clinical Treatment 20 (9/52%) Staffing 16 (7.61%) Communication 14(6.66%) Others including Diagnostic Tests, Waiting times, Environment, etc 88 (41.9%) It is important to note that PALS contacts also include requests for information relating to any of the above categories, as well as concerns or complaints. Non‐ specific advice continues to be the highest ranked category. PALS continue to deal with enquiries and concerns which benefit from an earlier response, and where the circumstances are deemed not to require a more rigorous investigation. Patient Advice & Liaison Service (PALS) (data source: Ullysses Safeguard System) 250 200 150 2010/11 100 2009/10 • • 50 Contacts with PALS remains consistent with the primary reason being Advice. • ‐ Apr May Jun Jul Aug Sep Oct There has been an overall decrease in the number of contacts received in October (209) compared to September (234). PALS Contacts by Directorate 2010/11 90 80 70 60 50 40 30 20 10 0 Cardiothoracic Services Clinical Sciences Estates & Facilities Medicine & Emergency Care Nursing Outpatients Services Surgical Specialties Women's And Children's Other August 16 8 10 31 12 21 72 15 9 September 14 13 3 52 6 25 83 25 13 October 14 15 4 44 10 12 83 17 11 The Directorate of Surgery continues to be the area involved in the greatest number of issues, with 83 contacts in October (83 in September). Of the 83 contacts in October, 27 were related to either the Fracture Clinic (Environment) or the Pain Management Clinic 40 (Waiting times due to clinical staffing issues). Section D: Patient experience – Comment Cards / NHS Choices • • • There has been a decrease in the number of comment cards received with 12 in October (compared to 26 in September, 22 in August, 40 in July, 39 in June). A recent review of wards/departments (21/10/10) has shown that “Get It Right” leaflets and comment cards are not on display in many areas. It is a requirement for the Trust (CNST Risk Management Standards and CQC Registration) that users of health services are able to easily assess processes via which comments or complaints can be made. This will be brought to the PECL meeting and members will be reminded of their responsibility to ensure areas within their directorates are in compliance with this. A similar review will take place before the end of the year. The highest number of cards received in the past have been primarily plaudits, however for October 2010, an equal number of cards were received regarding Waiting Times/Appointment Delays (4). The categories for October are broken down as follows:‐ Plaudits 4 Waiting Times/ Appointment Delays 4 Communication 2 Estates 2 Unfortunately not all comment cards provide details of specific areas within the hospital, nor contact details for a response to be sent. Of the 12 received in October, the directorates identified were:‐ Surgery 3 Medicine 2 Estates 2 "Get It Right" Comment Cards by Category April - October 2010 Compliments • Waiting times Air Conditioning Staff Attitude Hearing aid moulds Car Park Medical treatment Security Communication Estates Other • All comment cards are entered onto a central database for collation with existing Patient Experience reports. All cards have been responded to where it is requested, all concerns and comments are responded to and in every case, brought to the attention of the clinical directorates. Any action taken and the outcome is monitored by the Directorate of Nursing Quality Facilitator. Any significant trends or 41 issues are discussed at the PECL Group. Section D: Patient experience – Plaudits It is recognised that plaudits from patients/relatives/carers are a good indicator that the service provided by the Trust is meeting service user needs and expectations. The common themes in the formal plaudits to date are related to thanking staff for the care and attention received. The number of formal plaudits significantly with 37 received in October (17 in September). • Formal Plaudits (Data source: PET Office) 40 35 • 30 25 2009/ 10 20 2010/ 11 15 • 10 5 Apr May Jun Jul Aug Sep Oct All plaudits recorded Formal plaudits received in PET (acknowledged by Chief Executive) Plaudits via Comment Cards No. of plaudits compliments received in PALS No of plaudits received on wards/depts No of positive comments posted on NHS Choices Totals October 2010 37 4 8 101* 2 152 *This figure is reliant on the wards sending totals to the Nursing Directorate Quality Facilitator and does not indicate a downward or upward trend. • • It was reported in the March Performance Report that from April 2010, all plaudits would be reported including those received via the Patient Experience Team (PET) Office, “Get It Right” Comment Cards, PALS contacts and also plaudits received on the wards. Wards have been asked via their PECL representatives to submit the number of plaudits received on wards so that these can be added to the total plaudits received and also shown on the monthly ward metrics. It was reported in the April report that positive comments posted on the NHS Choices website would be included in this section. In order to monitor the comparison of formal plaudits received at the Trust, the chart below will be continued to track the year on year increase: Formal Plaudits Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar 2010/11 32 33 21 33 35 17 37 2009/10 17 9 15 20 19 26 22 12 27 25 11 16 2008/09 12 8 2 20 17 7 27 23 38 18 26 14 Total 208 219 42 212 Section D: Patient experience – Patient Experience Tracker • Patient Experience Tracker Overall Number of Responses (data source: Dr Foster Intelligence PET 3.0) 4500 4000 2009/10 3500 3000 2500 2010/11 • • 2000 Performance Improvement Trajectory Mar Feb Jan Dec Nov Oct Sep Aug Jul Jun May Apr 1500 Patient Tracker Satisfaction Scores (all questions) • • (data source: Dr Foster Intelligence PET 3.0) 2009/10 92% 90% 88% 86% 84% 82% 80% 78% 76% The response volume continues to exceed the Target of 3,500 per month, but with a slight decrease with 3,721 responses in October (3,886 in September). Wards and departments have been complimented for this achievement, however reminded of the need to offer the Patient Tracker to patients. For October, the overall patient satisfaction score was 87% (88% in September) against a target of 90%. The positive score to the question, “Would you recommend this Hospital?” in October was 95%. The Trust’s overall satisfaction score for the hand washing question achieved the target of 90% in October. However there were a number of areas where scores for this question, and others , fell below the target. These areas have been asked to provide action plans to PECL to address poor performance. The question “Overall, how you would rate the waiting time”, for Outpatient areas, scored a low satisfaction score with 64% in October. This will be reported to the November PECL meeting. Are you bothered by noise at night by hospital staff? 2010/11 (data source: Dr Foster Intelligence PET 3.0) 25% 20% Apr May Jun Jul Aug Sep Oct Nov Dec Jan Performance Improvement Trajectory Feb Mar 15% 10% 5% Oct‐10 Sep‐10 Aug‐10 Jul‐10 Jun‐10 Would you recommend this Hospital? May‐ 10 Apr‐10 0% During October, 21% of patients reported that they were disturbed by noise at night, this an increase on last month (18%). (data source: Dr Foster Intelligence PET 3.0) Were you satisfied with the food? •81% of patients in October responded they were satisfied with the food provided. (data source: Dr Foster Intelligence PET 3.0) 100% 100% 90% 90% 80% 80% 70% 43 70% Oct‐10 Sep‐10 Aug‐10 Jul‐10 Jun‐10 May‐10 60% Apr‐10 Oct‐10 Sep‐10 Aug‐10 Jul‐10 Jun‐10 May‐10 Apr‐10 Mar‐10 Feb‐10 Jan‐10 Dec‐09 Nov‐09 60% Section E: Efficiency & Effectiveness – Finance Overview Annual Plan: Year to date: FY Forecast: 3 3 3 3 = Regulatory concerns in one or more components. Significant breach of Terms of Authorisation is unlikely. For more detail see Appendix Key Points • Net I&E position break even in October, with £0.7m deficit year to date • Full year forecast held at £1.0m deficit at year end, with a risk of a further deterioration to £2.9m deficit • £6.8m CIP delivered against plan of £8.4m • The Financial Recovery Plan has to deliver £2.0m of further cost reductions • CTC income increased £0.2m in October versus previous months Financial Summary Year to Date Budget Var. Forecast Budget Var. £m £m £m £m £m £m 152.8 153.5 (0.7) 264.9 261.6 3.3 (143.4) (141.5) (1.9) (248.3) (242.7) (5.6) 9.4 12.0 (2.6) 16.6 18.9 (2.3) (0.7) 1.7 (2.4) (1.0) 1.0 (2.0) 6.8 8.4 (1.6) 14.0 15.2 (1.3) Net Cash Inflow/(Outflow) 13.3 5.1 8.2 0.1 (4.9) 5.1 Cash at End of Period 34.4 26.0 8.4 21.0 15.9 5.1 (11.7) (15.8) 4.1 (22.2) (30.3) Total Operating Income Total Operating Expenditure EBITDA Net Surplus/(Deficit) CIP Achieved Forecast Q3 Monitor Return • Net I&E position £1.3m deficit YTD • Financial Risk Rating: 3 Full Year Forecast Actual Capital Spending 44 8.1 Section E: Efficiency & Effectiveness – Full Year Financial Forecast Total Trust – Full Year Forecast Full Year Forecast by Directorate At Month 7 the full year forecast remains at a £1.0m deficit, £2.0m Forecast Full Year Actual £m worse than plan. However, there is a risk that the forecast will deteriorate to a £2.9m deficit if the financial recovery plan is not achieved, or if the PCT withhold further funding for work carried out. Directorate Commentary – Full Year Forecast • Protected Income forecast increased by £0.6m versus prior month, largely due to the anticipated release of reserves into the position. However, there remain significant risks on clinical income due to SWE PCT’s large deficit, and their proposed actions to reduce payments to the Trust. • Medicine’s forecast overspend has increased by £0.5m following a 3rd consecutive month of rising nursing expenditure, and ongoing higher expenditure on drugs. Year End Cash Forecast – The forecast of £21.0m cash at bank remains unchanged from prior month. Forecast Forecast FY Actual Full Year Change vs Variance Prior Month £m £m Protected and Other Income 235.0 1.9 0.6 Accident and Emergency Outpatient Services Women and Children Services Medicine Surgery Trauma and Orthopaedics Clinical Sciences Critical Care Cardiothoracic Centre Corporate Directorates Reserves (6.9) (8.2) (23.6) (36.6) (25.5) (8.9) (28.7) (9.1) (27.6) (43.9) 0.8 (0.9) (0.8) (1.9) (2.6) (1.1) (0.7) (2.0) (0.5) 0.8 (1.5) 7.0 (0.2) 0.2 0.3 (0.5) (0.2) (0.2) 0.1 (0.2) 0.2 (0.1) 0.0 16.6 (2.3) 0.0 Non Operating Items (17.5) 0.3 0.0 Net Surplus/(Deficit) (1.0) (2.0) 0.0 EBITDA 45 Section E: Efficiency & Effectiveness – Activity and Income (1) Detailed clinical income by point of delivery, and by directorate, is shown in the appendices. Elective Inpatients – October elective activity was 22 spells (3%) behind plan, with income £361k (15%) behind. The Point of Delivery - Activity Full Year Activity Plan YTD Actual YTD YTD Variance Variance to Budget to Profiled on 12ths Budget shortfall was largely driven by lower activity in Surgery, with 30 less spells (15%) than planned, resulting in a £222k shortfall in income. YTD Surgery remains 14% (196 spells) behind its activity plan, although the resultant income shortfalls are offset by higher daycase activity. CTC elective activity levels caught up a YTD shortfall in 7,326 23,716 41,062 297,744 24,629 93,487 Elective Inpatient (Spells) Day Case (Spells) Non-Elective (Spells) Outpatients (Atts) Outpatient Procedures Accident & Emergency (Atts) 4,151 14,959 23,125 179,347 16,191 44,722 (123) 1,125 (828) 5,663 1,824 (9,812) (279) 879 (828) 4,810 1,753 (9,812) October, but doing a less complex casemix than plan, and therefore giving a YTD income shortfall of £870k. Day cases – Activity was up again against plan 2% (51 spells) in October. However, within this activity, and across specialties, the casemix was less complex than plan, with significant activity and income underperformance in the CTC (worth £270k) only partially offset by higher activity in Clinical Sciences and T&O. YTD the CTC’s shortfall on daycase income amounts to £896k, which is only offset by higher activity in other directorates. Non‐Elective Inpatients – Across the Trust although activity was down 2%, income was a net £291k (4%) better than plan, largely due to higher activity in the CTC worth £271k. Although Obstetrics had a better month in October, with YTD activity lower than plan, and a lower casemix 46 Section E: Efficiency & Effectiveness – Activity and Income (2) (significant reduction in caesareans), income is Point of Delivery - Income £1,075k behind plan YTD for the specialty. This income is not subject to the 30% threshold, but is being offset elsewhere in the Trust by activity Current Month Actual £'000 Full Year Budget £'000 Month Var. to Budget £'000 YTD Actual £'000 YTD Var. to Budget £'000 that is. Given these activity changes, the cost base of the unit needs to be reduced to offset the loss of income. The table right now splits out the income lost due to activity above 2008/09 levels. For any emergency activity above 2008/09 levels, the Trust only gets paid 30% of normal tariff, and in October the Trust lost £292k due to excess activity. YTD the Trust has now lost £1,119k, and this rate of loss is expected to accelerate going into winter unless the Trust takes action to reduce admissions. Since it is likely to be loss 26,271 21,780 82,696 (1,233) 32,013 10,070 984 172,580 12,224 20,308 34,388 Elective Day Case Non Elective Emergency Threshold Adj.* Outpatients Accident & Emergency Partially Completed Spells CTC Transitional Funding Total Mandatory Outpatients (incl. procedures) Critical Care Other Non- Mandatory 1,977 1,805 7,373 (292) 2,818 814 (92) 82 14,486 (361) (111) 481 (189) (5) (25) (92) (302) 14,822 13,140 48,355 (1,119) 19,052 5,847 (40) 574 100,631 (1,064) 210 116 (400) 286 (27) (40) (919) 1,391 1,449 2,855 312 (243) (47) 7,605 10,396 20,135 439 (1,450) 389 239,501 Total Protected Income 20,181 (280) 138,768 (1,541) 1,740 20,382 261,623 Non-Protected Other Income Total Income 236 1,858 22,276 91 26 (162) 1,455 12,625 152,848 440 434 (667) making, the Trust is having to subsidise this activity, and furthermore it reduces capacity for elective work. Outpatients – Both first attendances and follow * All emergency activity above 2008/09 levels is only paid at 30% of tariff ups were behind plan by 6% and 4% respectively in the month, largely due to a significant drop in Critical Care – Income was £243k lower than plan in October due to underperformance in the CTC and NICU. CTC Critical activity during the school half term week at the Care is £883k behind plan YTD, and NICU £509k behind. However, due to the ongoing forecasted lower activity in NICU, end of October. Nevertheless, income was on the contract has been fixed with commissioners to avoid risk to both parties. plan for mandatory outpatients, and due to a YTD Other Non‐Mandatory – This includes £2,017k YTD for C‐QUIN assuming that all targets are achieved. A small provision is adjustment to Medicine, non‐mandatory held for non‐achievement of known elements, but the remainder has to be delivered for the Trust to receive this outpatients had higher income in the month. income. Non‐Protected – Income was £91k better than budget in the month due to higher RTA income in A&E. 47 Section E: Efficiency & Effectiveness – Expenditure Total pay expenditure was £351k (3%) overspent in October before the release of reserves, worth £380k. Medical staffing expenditure was overspent in October by £177k, although total spending is reducing (see graph right). The majority of this overspend is within A&E (see comment below in Directorate Key Issues) and Critical Care. Critical care spending is high due to long term sickness and extra lists due to the theatre power outage in September. Where agency staff are used for vacant posts, only programmed activities should be covered so that the agency premium is absorbed by SPA costs included within budgets. Nursing expenditure increased in the month to £504k over budget, with increases in all areas and particularly in Obstetrics. While agency costs across the Trust are reducing, this was largely due to higher recruitment, and the Trust now has more substantive nurses than ever before. Therefore, costs of using temporary staff have to be kept down to avoid the Trust failing to achieve the full year forecast. Drugs expenditure was £142k above budget in October, with high spending in General Medicine. Clinical Supplies expenditure was £210k (9%), with Clinical Sciences in particular overspent. 48 Section E: Efficiency & Effectiveness – CIP Year to date the Trust has achieved £6.8m CIP savings, compared to a target of £8.4m, resulting in a YTD variance of £1.6m. This variance has deteriorated in month 7 by £0.5m due to under performance in a number of clinical directorates, as well as Estates and Facilities. Key elements driving this under performance include slippage in recruiting A&E doctors substantively, lower CTC clinical income, failure to close escalation areas, failure to realise savings from the theatre closure, and slippage on achieving non‐pay savings through standardisation of consumables. Non‐achievement in Estates is largely linked to the delay in implementing Steam Cuisine. At month 7 the risk‐weighted full year forecast position will be unaffected. Several central non‐recurrent items are held to offset these slippage gaps. CIP delivery is £13.2m against a target of £15.2m, £0.1m less than forecast in September (see appendix for risk weighted forecast). The forecast still includes £1.0m of schemes rated as amber risk, but negligible schemes still rated as a red risk. The forecast full year CIP before risk adjustment is £14.0m, £1.3m short of target. Shortfalls in CIP achievement are largely explained by slippage in the implementation timing of savings, and therefore the recurrent Quality assessment of all CIP schemes is shown on the dashboard, and 21 schemes will deliver improved quality. • Of the five schemes awaiting quality assessment three of these relate to generalised non‐pay savings. Each non‐pay saving suggested will have a quality assessment undertaken on an individual basis. All clinical directorates have Resource Efficiency Groups set up to bring together staff at all levels, from clinician to ward hostess, with the procurement team to identify smarter purchasing options, more efficient ways of working and ensure quality is maintained/improved in all changes. • The CTC is implementing a change in clinical practice that is subject to clinical audit before quality sign‐off can be given, and the final decision on this is awaited shortly. 49 • Surgical Services have successfully transferred a ward to the Medical Directorate, and this should facilitate improved patient care and financial control, as medical patients will be treated within speciality rather than as outliers. Section E: Efficiency & Effectiveness – Cash Management The overall cash variance this month was £8,389k higher than plan and the larger variances in specific items are commented below. Debtors £1.4m prepayment accruals due to timing differences on various accounts. £1.1m over performance not included in annual plan. Creditors £1.6m difference in plan and actual due to accruals for SWE PCT therapy services. £3.6m increase in accruals against planned movement. £0.6m re agency doctor invoices delayed payments due to Cash Balance Variances YTD queries being raised. £’000 £2.4m in advance from Specialist Commissioning in advance of November contract payment. £0.8m other timing differences. Capital £’000 Cash balance per Budget EBITDA Stock 25,963 (2,606) 409 Capital spending is £4.1m behind plan YTD. For further Debtors details on the capital programme, see the Look and Feel Creditors 9,051 Net Operating Cash flow variance 4,401 Capital Expenditure 4,100 Other (112) section. The Balance Sheet and Cash Flow Statement are shown in (2,453) the appendices. Net cash inflow/(outflow) variance Actual cash balances 50 8,389 34,352 Section E: Efficiency & Effectiveness – Financial Risk The key risks to achieving the financial plan in 2010/11 are: • PCT Turnaround programme. • Non‐delivery of the Financial Recovery Plan. • Failure of PCT to pay for activity due to cash flow problems; • Medical non‐elective patient outliers reducing capacity for elective work; • The PCT decommissioning significant elements of activity, in year, and into 2011/12; • Directorates failing to implement their cost improvement plans resulting in significant over spends; • The Trust reducing activity but not reducing costs to offset the loss of income; • Failure to achieve the internal activity plan within the bed capacity constraints; • Failure to deliver the requirements of CQUIN and thus not receiving the 1.5% payment; • Not meeting the new contract requirements and receiving penalties; • Failure to record all clinical activity accurately; • Meeting the quality and accuracy of coding required by the new contract and PCT commissioning team; Mitigation and Recovery Plan • Slippage of capital programme to mitigate PCT cash flow problems; • Weekly metrics review of pay and activity, with Chief Executive, Acting Director of Finance, Clinical General Managers and Director of Operations and Service Development; • Monthly performance review meetings with each directorate; • Fortnightly CIP review meetings; • CIP dashboard with workbook and milestones for all schemes; • Weekly Vacancy Control Group reviewing all posts for recruitment; • Overseas recruitment plan for medical staff vacancies; • Increased sign‐off control for expenditure; • Management of unauthorised and authorised absence; • Controls over bank and agency usage; • Utilisation of outpatient clinic space; • Utilisation of theatre sessions; • CTC activity recovery plan agreed from September 2010; • Increased directorate KPI’s to monitor performance; • Action plan to reduce directorate/corporate overheads. 51 Section E: Efficiency & Effectiveness – I&E Statement Full Year Month Plan Budget Actual £'000 £'000 £'000 £'000 Year to Date Budget Variance £'000 Actual Budget Variance £'000 £'000 £'000 INCOME 240,320 239,501 20,181 20,461 138,768 140,309 1,740 1,740 Protected activities Non-protected activities 236 145 (280) 91 1,455 1,015 (1,541) 440 19,672 20,382 Other operating income 1,858 1,832 26 12,625 12,191 434 261,733 261,623 22,276 22,438 (162) 152,848 153,515 (667) (165,301) (164,506) (13,297) (13,804) 507 (90,668) (95,971) (109) (401) (516) (38) (478) (6,543) (351) (6,191) (165,410) (164,907) (13,813) (13,842) 29 (97,211) (96,322) (889) (12,823) (13,160) Drugs (1,334) (1,191) (142) (8,467) (7,989) (478) (30,061) (28,787) Clinical Services (excl. drugs) (2,572) (2,362) (210) (16,980) (16,157) (823) (34,522) (35,866) Other Non-Pay (excl. depreciation) (3,129) (3,009) (120) (20,759) (21,010) 252 (46,205) (45,156) (1,050) (143,417) (141,478) (1,939) PAY NHS Non-NHS 5,303 NON-PAY (77,406) (77,813) (242,816) (242,720) 18,917 18,903 (11,057) (11,057) (850) 450 (850) 464 (6,440) (6,440) 1,020 1,020 (402) (402) 618 618 Total Expenditure EBITDA Depreciation (7,034) (6,562) (472) (20,847) (20,404) (443) 1,429 2,035 (606) 9,431 12,037 29 (6,270) (6,334) (894) Profit/(loss) on disposal (15) Interest Payable (70) Interest Receivable Capital dividends payable Net surplus/(deficit) Asset Impairment Retained surplus/(deficit) (923) - (15) (15) (71) 1 (372) 29 39 (10) (514) (537) 23 (35) 543 (578) (35) 543 (578) 165 (3,596) (657) (657) - (2,606) 64 (15) (496) 124 270 (105) (3,757) 1,721 1,721 161 (2,377) - 52 (2,377) Section E: Efficiency & Effectiveness – I&E Run Rate 09/10 Q1 Ave Q2 Ave Q3 Ave Actual Actual Actual INCOME Protected activities Non-protected activities Other operating income PAY NHS Non-NHS NON-PAY Drugs Clinical Services (excl. drugs) Other Non-Pay (excl. depreciation) Total Expenditure EBITDA Depreciation Profit/(loss) on disposal Interest Payable Interest Receivable Capital dividends payable Net surplus/(deficit) 09/10 10/11 Jan Actual Feb Actual Mar Actual FY Actual Apr Actual May Actual Jun Actual Jul Actual Aug Actual Sep Actual Oct Actual £'000 £'000 £'000 £'000 £'000 £'000 £'000 £'000 £'000 £'000 £'000 £'000 £'000 £'000 19,262 154 1,915 21,331 19,539 193 1,865 21,597 19,599 173 1,994 21,766 20,103 112 2,044 22,258 20,493 197 2,164 22,855 21,619 218 2,246 24,084 257,015 2,256 25,771 285,042 19,778 124 1,696 21,598 19,797 173 1,758 21,728 19,673 227 1,798 21,698 19,494 196 1,873 21,563 19,807 250 1,761 21,818 20,038 248 1,882 22,168 20,181 236 1,858 22,276 (12,080) (12,252) (12,559) (12,889) (12,557) (12,897) (1,088) (1,027) (1,267) (1,361) (1,290) (1,491) (13,169) (13,280) (13,826) (14,250) (13,847) (14,388) (161,578) (15,554) (177,132) (12,783) (12,853) (12,783) (12,802) (13,078) (13,072) (13,297) (1,112) (1,149) (1,152) (972) (814) (828) (516) (13,895) (14,002) (13,935) (13,774) (13,892) (13,900) (13,813) (1,020) (1,051) (1,193) (1,312) (1,161) (1,511) (2,338) (2,436) (2,582) (2,203) (2,336) (2,755) (2,902) (2,939) (3,383) (3,584) (3,696) (3,858) (6,260) (6,426) (7,158) (7,098) (7,193) (8,124) (19,428) (19,705) (20,984) (21,348) (21,039) (22,512) (14,969) (31,945) (42,191) (89,104) (266,236) (1,312) (1,066) (1,365) (862) (1,208) (1,320) (1,334) (2,335) (2,541) (2,586) (2,124) (2,220) (2,602) (2,572) (2,955) (3,038) (2,374) (3,098) (3,013) (3,152) (3,129) (6,602) (6,645) (6,325) (6,083) (6,442) (7,074) (7,034) (20,497) (20,647) (20,261) (19,857) (20,333) (20,974) (20,847) 1,902 1,891 782 910 1,816 1,572 18,805 1,101 1,081 1,437 1,706 1,484 1,193 1,429 (931) (39) 16 (539) (942) (0) (51) 20 (539) (953) (39) 21 (539) (992) (37) 24 (149) (767) (37) 1 (500) (979) 78 (38) 13 (448) (12,170) 78 (534) 231 (6,487) (898) (37) 3 (537) (898) (38) 45 (537) (899) (37) 16 (537) (894) (37) 28 (537) (894) (38) 22 (537) (894) (115) 23 (397) (894) (15) (70) 29 (514) 411 380 (728) (244) 513 197 (77) (368) (348) (20) 266 38 (190) (35) 53 Section E: Efficiency & Effectiveness – Clinical Income by POD Full Year Current Period Budget £'000 Actual £'000 Year to Date Budget Variance £'000 £'000 Actual £'000 Budget Variance £'000 £'000 26,271 21,780 81,463 Elective Day Case Non Elective 1,977 1,805 7,080 2,338 1,917 6,789 (361) (111) 292 14,822 13,140 47,237 15,886 12,931 47,520 (1,064) 210 (284) 16,313 15,699 32,013 Outpatients - 1st Outpatients - Follow Up Total Outpatients 1,440 1,378 2,818 1,439 1,385 2,823 1 (7) (5) 9,439 9,613 19,052 9,563 9,203 18,766 (124) 410 286 10,070 984 172,580 Accident & Emergency Partially Completed Spells CTC Transitional Funding Total Mandatory 814 (92) 82 14,486 839 82 14,788 (25) (92) (302) 5,847 (40) 574 100,631 5,874 574 101,551 (27) (40) (919) 6,931 20,308 5,395 6,362 8,023 4,201 3,955 5,125 6,885 3,587 (3,851) 66,921 GP Direct Access Critical Care Excluded Drugs Excluded Devices Outpatients - Attendances Outpatients - Procedures Community Midwifery Renal Other Non-Mandatory C-Quin Income Reserves Total Non-Mandatory 676 1,449 601 376 945 446 330 326 601 288 (342) 5,696 578 1,692 556 459 708 370 330 284 575 299 (178) 5,674 98 (243) 45 (83) 237 75 42 26 (11) (164) 22 4,457 10,396 3,440 2,988 4,900 2,705 2,307 3,195 4,140 2,017 (2,410) 38,137 4,043 11,847 3,399 3,141 4,703 2,462 2,307 2,990 4,021 2,092 (2,246) 38,759 414 (1,450) 42 (152) 196 243 205 119 (75) (164) (622) 239,501 Total Protected Income 20,181 20,461 (280) 138,768 140,309 (1,541) 54 Section E: Efficiency & Effectiveness – Balance Sheet March 2011 Plan Current Period Budget £'000 £'000 210,250 210,250 15,889 15,889 12,975 12,975 28,864 28,864 22,040 22,040 6,824 6,824 217,074 217,074 22,431 22,431 194,643 194,643 114,176 114,176 53,153 53,153 1,153 1,153 26,161 26,161 194,643 194,643 194,643 194,643 Actual Mar 10 Budget Variance £'000 £'000 195,314 201,780 (6,466) 191,896 34,352 25,963 8,389 20,924 Other current assets 13,395 11,857 1,538 19,000 CURRENT ASSETS 47,747 37,821 9,926 39,924 CURRENT LIABILITIES, due within one year 29,304 23,550 5,754 27,079 Net current assets/(liabilities) 18,443 14,271 4,172 12,845 Total assets less current liabilities 213,758 216,051 (2,293) 204,741 20,192 20,215 (23) 10,499 193,566 195,836 (2,270) 194,242 114,176 114,176 0 114,176 53,153 53,153 - 53,153 1,350 1,243 107 1,370 24,886 27,263 (2,377) 25,543 193,566 195,836 (2,270) 194,242 193,566 195,836 (2,270) 194,242 - - - - 16,000 16,000 - 16,000 16,000 16,000 - 16,000 NON-CURRENT ASSETS Cash NON-CURRENT LIABILITIES, due after one year Total assets employed Public dividend capital Revaluation reserve Donated asset reserve Income & expenditure reserve TAXPAYER'S EQUITY Total funds employed £'000 Actual £'000 FINANCING FACILITIES - - 16,000 16,000 16,000 16,000 NHS Non-NHS Total committed and unused financing facilities 55 Section E: Efficiency & Effectiveness – Cash Flow Statement Full Year Month Plan Budget Actual £'000 £'000 £'000 18,917 18,903 (217) (53) (217) (53) EBITDA Year to Date Budget Variance £'000 1,429 Transfers from reserves (18) £'000 2,035 (18) Actual Budget Variance £'000 (606) (1) 9,431 (129) £'000 £'000 12,037 (2,606) (128) Stocks 163 (0) 163 355 6,445 6,445 Debtors 314 (737) 1,051 5,096 7,549 (2,453) (5,519) (5,519) Creditors 1,790 (100) 1,890 3,844 (5,093) 8,937 (1) (1) Provisions Net operating cash flow (27) - 19,572 19,558 (30,298) (30,298) (167) (154) (10,894) (10,894) (6,440) (6,440) Capital dividends paid 52 138 (0) PDC received/(repaid) - - 12,386 12,386 (4,948) (4,948) Capital expenditure Net interest received/(paid) Net cash flow before financing Net Loans received/(repaid) Net movement in cash 3,651 1,180 (1,967) (2,902) (4) 1,680 (32) 1,700 45 (1,677) (1,539) (27) 2,471 936 (49) 3,357 (86) (32) 3,239 (42) (53) (1) (1) 409 (41) 18,555 14,310 4,245 (11,673) (15,773) 4,100 (171) (7) (164) 6,711 (1,470) 8,181 (3,168) (3,220) 52 (0) 0 9,793 9,793 0 13,336 5,103 8,233 56 Section E: Efficiency & Effectiveness – Monitor Financial Risk Rating Based on financial performance metrics, Monitor allocate foundation trusts a finance risk rating between 1 and 5, where 1 is highest financial risk and 5 is lowest. The finance risk rating is made up of five components, with the Trust’s YTD and forecast position as follows: Financial Risk Rating Metric EBITDA Margin EBITDA, % Achieved ROA I&E Surplus Margin Liquid Ratio Weighted Average Criteria Underlying Performance Achievement of Plan Financial Efficiency Financial Efficiency Liquidity YTD Actual Rating 6.2% 3 82.0% 3 2.4% 2 -0.4% 2 43.3 4 2.9 Forecast Full Year Actual Rating 6.3% 3 87.7% 4 2.5% 2 -0.4% 2 47.2 4 3.0 Current Risk Ratings: Weight 5 4 25% 11% 9% 10% 100% 85% 20% 6% 5% 20% 3% 2% 25% 60 25 100% 3 5% 70% 3% 1% 15 2 1% 50% -2% -2% 10 1 <1% <50% < -2% < -2% <10 Weighted Average Risk Rating Definitions Rating 5 - Low est risk - no regulatory concerns Rating 4 - No regulatory concerns Rating 3 - Regulatory concerns in one or more components. Significant breach of Terms of Authorisation is unlikely Rating 2 - Risk of significant breach in Terms of Authorisation in the medium term, e.g. 9 to 18 months in the absence of remedial action Rating 1 - Highest risk - high probability of significant breach of Terms of Authorisation in the short-term, e.g. less than 9 months, unless remedial action is taken Over-riding Monitor Metric Rules The overall risk rating is a w eighted average of the five metrics, but there are four rules that overide this average: 1. If any one metric is ranked at 1 or 2 than the maximum Trust rating is 3 2. If any 2 metrics are ranked at 1 or 2 then the maximum Trust rating is 2 3. If any 2 metrics are ranked at 1 then the maximum Trust rating is 1 4. If any metric is ranked at 1 then the maximum Trust rating is 2 NB For the pupose of these over-riding rules, the ROA and I&E Surplus metrics are averaged together, leaving a total of 4 metrics against w hich these rules are tested Glossary of term s EBITDA EBITDA EBITDA Margin EBITDA % Achieved Financial Efficiency ROA I&E Surplus Margin Liquidity Liquid Ratio EBITDA is earnings before deducting interest, taxes, depreciation and amortisation. It also excludes exceptional items and dividends. It is a measure of the performance of the "underlying business" i.e. the surplus/deficit from day to day operations and is similar to the directorate financial statements. This is EBITDA as a percentage of total income. This is designed to measure the ability of the Trust to achieve its financial plans. The target is therefore 100% or more. Return on assets measures how efficiently the Trust uses its assets. It is defined as the Net Surplus before dividends as a percentage of the total assets of the Trust. This is the Net Surplus as a percentage of total income. This ratio measures the Trust's ability to pay its bills from liquid assets (assets that are easily realisable), and is intended to show w hether the Trust can continue to pay its bills in the short term. The metric show s for how many days the Trust could continue to pay its bills just using its net w orking capital. Net w orking capital (i.e. liquid assets) consists of cash in bank and debtors due in less than one year, less creditors due in less than one year. 57 Section E: Efficiency & Effectiveness – CIP Board Dashboard 58 Section E: Efficiency & Effectiveness – CIP Directorate Dashboard 59 Section E: Efficiency and Effectiveness – Workforce Vacancies 10.0% 8.0% Frozen Vacancies 6.0% Active Vacancies 4.0% Target Vacancies 2.0% A pr‐1 0 M ay‐1 0 Jun‐1 0 Jul‐1 0 A ug‐1 0 Sep‐1 0 O ct‐1 0 Nov‐1 0 Dec‐1 0 Jan‐1 1 Feb‐1 1 M ar‐1 1 0.0% The vacancy rate for the month of October 2010 is 8.35% and the annual rate (in the 12 months to October 2010) is 8.82%. The vacancy position within nursing and midwifery has reduced further to 7.79% in October. The vacancy control group continues to meet to review the workforce position. Membership has been expanded to include representation from the service planning to ensure activity projections and any planned PCT changes on activity are included in discussions prior to recruitment decisions taking place. A review of the overall vacancy position will also be discussed on a weekly basis. The Trust are following the recent published guidance on the EOE Employment Framework whereby all positions are now advertised on the NHS Jobs Restricted Website for a period of 7 days prior to national advertising. This provides an opportunity for employees placed at risk to apply for positions locally. Data Source – Electronic Staff Record The annual rate of turnover (i.e., the number of staff retiring or resigning) in the 12 months to October 2010 is 10.83 %, and the monthly rate is 0.69%. It is predicted that turnover will stabilise at around 10‐11% by year end. Staff Turnover 1.4% 1.2% 1.0% 0.8% 0.6% 0.4% 0.2% 0.0% Data Source: Electronic Staff Record Mar‐11 Feb‐11 Jan‐11 Dec‐10 Nov‐10 O ct‐10 Sep‐10 Aug‐10 Jul‐10 Jun‐10 May‐10 Apr‐10 Staff Turnover 60 Section E: Efficiency and Effectiveness – Workforce Appraisal compliance is monitored on a monthly basis. In October performance increased to 77% with a further 2% of the workforce with appraisal dates confirmed. Weekly discussions are taking place with senior managers to ensure that those employees without a scheduled appraisal date are followed up and dates are confirmed. Performance will continue to be monitored on a fortnightly basis to ensure improvements continue to be made. Directorates have set milestones Staff Appraisals 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% Appraisals Mar‐11 Feb‐11 Jan‐11 Dec‐10 Nov‐10 Oct‐10 Sep‐10 Aug‐10 Jul‐10 Jun‐10 May‐10 Data source: Electronic Staff Record Sickness Absence 4.5% 4.0% 3.5% 3.0% 2.5% 2.0% 1.5% 1.0% 0.5% 0.0% Mar‐11 Feb‐11 Jan‐11 Dec‐10 Nov‐10 Oct‐10 Sep‐10 Aug‐10 Jul‐10 Jun‐10 May‐10 Apr‐10 Sickness Absence The Trust’s sickness figure for the month of October 2010 is 3.38% and the annual figure (based on a 12‐month rolling average) is 3.68 %. The annual Chartered Institute of Personnel and Development Absence Management Survey 2010 states that the average level of absence within the Health Sector is 4.7%. The Trust position is considerably lower than this. Detailed weekly reviews of all employees absent the previous week is undertaken between the personnel team and the appropriate directorate manager. This will continue to ensure we are consistently addressing all episodes of non attendance. Data source: Electronic Staff Record 61 Section F: Look and Feel – Estates Number of Job Requests Statutory Maintenance Completed 3,400 100% 3,200 95% 3,000 2,800 20010/11 2,600 2009/10 2,400 90% In M onth Target 85% Mar‐11 Feb‐11 Jan‐11 Dec‐10 Nov‐10 Oct‐10 Sep‐10 Aug‐10 Jul‐10 Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar Jun‐10 Apr‐10 2,000 May‐10 80% 2,200 The number of job requests in October reduced sharply compared to September and was 8% lower than October last year. The reduction in jobs may be related to the additional cost control measures introduced whereby only H&S related maintenance requests are actioned. Overall, maintenance performance in October, 7 of the 8 KPI measures improved compared to September. All 3 planned preventative maintenance targets were fully met in October. For the first time this year, the Estates team fully met their urgent response stretch target and overdue work reduced markedly. Planned Preventative Maintenance (PPM) Completed Water Systems Maintenance Completed 100% 100% 95% 90% 90% In M onth 80% In M onth 85% Target 70% Target M ar‐1 1 Feb‐11 Jan‐1 1 Dec‐10 Nov‐10 O ct‐10 Sep‐10 A ug‐1 0 Jul‐1 0 Jun‐10 May‐1 0 M ar‐1 1 Feb‐11 Jan‐1 1 Dec‐10 Nov‐10 O ct‐10 Sep‐10 A ug‐1 0 Jul‐1 0 Jun‐10 M ay‐1 0 A pr‐1 0 Data given is provided from the Estates ‘Shire’ work management system A pr‐1 0 60% 80% 62 Section F: Look and Feel – Cleaning Cleaning Scores ‐ High Risk Areas Cleaning Scores ‐ Very High Risk Areas 98% 96% Very High Risk Actual 98% Target 96% 94% High Risk Actual Target 94% 92% 92% Mar‐11 Feb‐11 Jan‐11 Dec‐10 Nov‐10 Oct‐10 Sep‐10 Aug‐10 Jul‐10 Jun‐10 Apr‐10 May‐10 90% Mar‐11 Jan‐11 Feb‐11 Dec‐10 Nov‐10 Oct‐10 Sep‐10 Aug‐10 Jul‐10 Jun‐10 May‐10 Apr‐10 90% The cleaning service is monitored according to a risk assessment undertaken in accordance with the National Standards for Cleanliness in the NHS. The Trust has a stretch target to achieve 98% for Very High risk areas and 95% for High Risk areas but to have only a limited number of areas below the standard of 96% and 93% respectively. In Octber 2010 there was one occasion when the weekly monitoring of a High Risk area showed a score of less than 93%. This related to Horndon Ward with a score of 87%. Action was taken immediately to address the issues found and the ward did not fall below the trigger point again during the month. There were no Very High Risk areas that scored less than 96% in the month. Cleaning Scores ‐ Low Risk Areas Cleaning Scores ‐ Significant Risk Areas 95% 96% 94% 92% 90% 88% 86% 84% 82% 80% 90% Significant Risk Actual Target Low Risk Actual 85% Target 80% 75% Data given on the graphs above comes from the Innovise cleaning monitoring system. Mar‐11 Jan‐11 Feb‐11 Dec‐10 Nov‐10 Oct‐10 Sep‐10 Aug‐10 Jul‐10 Jun‐10 May‐10 Apr‐10 Mar‐11 Feb‐11 Jan‐11 Dec‐10 Nov‐10 Oct‐10 Sep‐10 Aug‐10 Jul‐10 Jun‐10 Apr‐10 May‐10 70% 63 Section F: Look and Feel – Capital Investment YTD YTD Spend Oct Budget 2010 Oct 2010 Annual Allocation £000 10,020 2,068 499 600 5,359 £000 £000 Forecast Year End Spend £000 A&E/Fracture Clinic Redevelopment Catering Services Review Windows Ward Refurbishment Other estates projects 3,368 607 387 649 2,392 5,845 1,477 241 600 2,844 6,060 1,763 387 649 4,177 3,373 Electronic Medical Records 2,264 IT Strategy - Infrastructure/Systems 1,534 993 1,777 1,122 3,373 1,864 875 2,189 2,307 589 120 16,685 20,700 4,249 Clinical Equipment - Replacement/New 1,746 General Contingency 30,178 ‐ 10,805 Work is progressing with the capital programme including: Security Team Office/CCTV Monitoring The new Security Office in the main reception project completed in October. The remodelled facility provides a fully integrated CCTV monitoring suite to ensure the Trust has an effective & compliant system utilising enhanced digital technology to improve image quality. Ward Refurbishment The former Fleming Ward refurbishment completed on 5th November and re‐opened as James McKenzie Ward with patients moved from the Frank Ahrens cardiac ward. The refurbished ward incorporates features to prevent infections such as curved surfaces, air‐tight light fittings and easy‐clean fixtures. The Former Frank Ahrens will be renamed Acute Medical Ward (West) and integrated with the adjacent MAU ward renamed Acute Medical Unit (East). Catering Project The Restaurant refurbishment work started on 16th October and will complete by the end of the year. A temporary restaurant facility will be provided whilst the works progress. 4 Bed Bay of the Refurbished James McKenzie Ward November 2010 The first 4 wards all located in the Jubilee Wing went live with the new ‘Steam Cuisine’ service on 10th November. The wards will be rolled‐out progressively over the next 2 months. The service is being provided temporarily from a mobile cold‐store facility on level A re‐using the link corridor originally built for the decant theatres. The replacement level B Kitchen facility will be tendered shortly. 64 This page is left blank intentionally 65 BOARD OF DIRECTORS PART 1 MEETING DATE: 24 NOVEMBER 2010 AGENDA ITEM: (2) 6 PROGRAMME MANAGEMENT OFFICE UPDATE REPORT OF THE PROGRAMME DIRECTOR AND DIRECTOR OF CONTINUOUS IMPROVEMENT Purpose This report is intended to update the Board of Directors on the progress and achievements of the projects overseen by the Programme Management Office (PMO). Composition of the Report No. of pages: 5 No. of appendices: 2 Summary - Key Issues • • • • • The PMO is currently overseeing 32 projects. At present, there are 2 projects in the pipeline. Of the 1,289 milestones (or actions) that were due for completion since the start of the programme, 54 are outstanding (4%). At the current time, there are 74 key performance indicators (KPIs) being monitored by the Programme Board. Of these, 17 or 23% are not being fully met. The A&E project has been reinstated on the dashboard and improvements are continuing. Anticipated Outcome (complete this if appropriate) Recommendation(s)/ Decision Required The Board of Directors is asked to note the progress made in relation to the work of the PMO and the progress against the milestones of the projects. Key Risks and Board Assurance • Failure to deliver the programme will lead to the potential of additional intervention by Monitor. Regular reporting to Monitor to provide confidence of continuous improvement • The increasing challenging financial context will require sustained performance improvement to deliver the financial plan. Cost improvement plans to be monitored using the principles of the PMO and 66 • key projects to be overseen by the PMO. Failure to deliver the QIPP initiatives proposed by NHS South West Essex may lead to additional financial pressure, in addition to those internally generated. Major QIPP projects will be managed through the PMO to ensure visibility of service and financial impact and timely delivery. Implications Projects will impact across the 4 key themes of the organisation’s strategy together with compliance with requirements of the regulators such as the Care Quality Commission (CQC) and Monitor and the commissioners, NHS South West Essex. Implications of not accepting recommendation(s): None Acronyms / Abbreviations used in the Report (where not stated): Monitor – The independent regulator of NHS foundation trusts PwC – PricewaterhouseCooper HSMR – Hospital Standardised Mortality Ratio TIA – Transient Ischaemic Attack A&E – Accident and Emergency Department QIPP – Quality, Innovation, Productivity and Prevention Author: Adam Sewell-Jones Status: Programme Director Date: 15 November 2010 67 PROGRAMME MANAGEMENT OFFICE UPDATE REPORT AS OF 12 NOVEMBER 2010. 1. Introduction Following the intervention by Monitor in November 2009, the Trust, in partnership with PricewaterhouseCoopers(PwC), set up a Programme Management Office (PMO). The role of this office is to co-ordinate the delivery of a set of projects such that the anticipated benefits can be realised within the timescales of the programme and in the future. Projects will be managed through this process where they are seen to be critical to the strategic work of the Trust, are considered to be a core business function or outcome, or where they are indicated by regulatory or contractual concerns. The PMO consists of: Adam Sewell-Jones Ruth Taylor Andrea Saville Iris Smith Katy John Annemarie Halls Programme Director and Director of Continuous Improvement Deputy Programme Director Programme Manager (part time) Programme Manager (part time) Programme Assistant Programme Administrator 2. The Current Programme The PMO is currently overseeing 31 projects, many of which were originally included in the Quality Improvement Plan: Patient Experience and Safety agreed with the Commissioners and NHS East of England in the summer of 2009. Others have been added following concerns expressed by either Monitor or the Care Quality Commission (CQC) or following additional alerts raised by the Dr Foster Intelligence System. In addition, some projects remain under the monitoring of the PMO. The key themes for these projects are: • Capacity management and discharge • Reducing HSMR • Care Quality Commission Registration Conditions • Risk management standards • Health and Safety Executive requirements • The Department of Health Productive series • Management and Prevention of Pressure ulcers • Response and management of the deteriorating patient. • Quality, Innovation, Productivity and Prevention (QIPP) programme Each project has a Project Manager, Clinical Lead and Executive Sponsor. The Project Manager (with the support of the Clinical Lead) meets with the PMO weekly, or less frequently where appropriate, to review progress against actions and performance against the agreed key performance indicators (KPIs). The Programme Board, consisting of the executive directors, the PMO team and a non-executive director meets fortnightly to review the progress of all projects and to discuss any areas of concern or high risk. Action is taken to address all areas of concern following this meeting. 2.1 Closed Projects October During October 2010, no projects were closed. 2.2 New Projects October 68 There were 8 new projects established in November, all of which are related to the QIPP initiative to reduce the new to follow up ratios to the national median or upper quartile performance. 2.3 Suspended Projects October 1 previously suspended project has been reactivated: A&E Improvement Project. This project had been suspended to facilitate the work required to commission the new A&E build and was reactivated when the move into the new area was successfully completed. 3. The Pipeline In addition to the projects mentioned above, the PMO supports a “pipeline” of projects which may or may not be translated into projects to be overseen by the office. At the current time, there are two projects in the pipeline, one related to end of life care and one relating to the national dementia strategy. 4 Performance to date As of Friday 12 November 2010, there were: 1 22 9 red; amber; and green rated projects. Of the 1,289 milestones (or actions) in the current projects that were due for completion since the start of the programme, 54 are outstanding (4%). Reasons for the variance are challenged by the PMO and remedial action identified to reduce the slippage. As failure to deliver against milestones can be seen as poor performance on behalf of the Project Lead, the PMO has been working closely to reduce this number to zero. The dashboard, which is prepared weekly, is attached for information at Appendix 1 and reflects the progress of all projects as of close of play on Friday 15 October 2010. At the current time, there are 74 key performance indicators being monitored by the Programme Board. Of these, 17 or 23% are not being met. RAG rating is based on the following performance tolerance levels: less than 3% from target is green, between 3-6% variance is amber and over 6% is red. This is deterioration on previous weeks and reflects the number of amber projects at the time of the report. It also reflects the HSMR position following the national re-basing as a number of the projects have this as a KPI. It should be noted that this position (and that of the milestones) is affected by the removal of the closed projects from the monitoring and reporting position. 5 Key Achievements to Date There have been a number of achievements since the introduction of the PMO. Most notable are: • HSMR for the top 5 HRG chapters originally identified in the Quality Improvement Programme in 2009 have significantly improved, with none now being indicated 69 as red or significantly worse than average over the 12 month rolling average as can be seen below: Sep 2009 Oct 2009 Nov 2009 Dec 2009 Jan 2010 Feb 2010. Mar 2010 Apr 2010 COPD 133.9 129.4 127.2 119.9 112.3 104.8 103.6 102.1 Pneumonia 117.1 111.1 112.1 108.9 102.8 103.2 98.3 98.1 Stroke 105.1 101.7 98.2 90.7 86.6 83 80.4 77.2 AMI 128.6 129.8 123.6 126.3 131.2 126 119.5 119.2 Heart 133.7 130 129 124.5 122.5 119.7 112.2 104.6 Failure Trust 117.5 114.3 110.9 107.9 105.6 102.5 96 3 94.9 Overall (data source: Dr Foster Intelligence System as of 1 November 2010) • • • • • • • • • • • May 2010 Jun 2010 1 Jul 2010 2 Aug 2010 101.8 99.3 80.1 110.1 94.3 118.8 101.3 89.5 119.2 110.1 115.3 99.7 89.5 108.6 107 109.7 99.7 88.6 116.7 112.3 93.1 99.9 98.3 97.4 Sustained achievement of increased cleaning monitoring scores for high and very high risk areas Approx 70% of all children arriving in the A&E department are seen in the Children’s Area. In excess of 90% of those attending the Children’s A&E currently express satisfaction with the service. Weekend discharges within the Directorate of Medicine and Emergency Care have increased to 16% of the total weekly discharge. Nurse facilitated discharge protocol has been successfully implemented in both the medical and surgical directorates. 98% target for A&E patients to be admitted or discharged within 4 hours has been achieved consistently since March 2010 with average journey time through the department of 196 minutes (weel commencing 8 November). Length of stay for patients with a stroke is below 20 days and HSMR is currently 89.5 (after re-basing). A one stop clinic has been introduced for low risk TIA patients to be seen within 7 days of the onset of symptoms. The Principles of Care Audit results for October indicate that: o 98% of patients had their baseline observations recorded within 2 hours of admission o 99% of patients had an accurate PARS score calculated with 90% appropriately escalated to the relevant team. o 85% of patients had their pressure areas assessed within 2 hours of admission o 97% of patients had a care plan In October 96% of patients who were admitted with Heart Failure were seen within 48hrs by the Nurse Specialist in Heart Failure and 97% received an ECHO within 48 hours of admission. Reporting times for radiological examinations have improved: over 90% of urgent requests are being reported within 24 hours and over 60% are reported within 7 days. In addition, 94% of reports are completed using digital dictation. 1 Dr Foster re-based HSMR based on 2009/10 national averages. The overall result is that all HSMR values are likely to increase. The figures for June 2010 reflect the effect of this rebasing. 2 None of the HSMR values for this period are denoted as significantly worse than expected (i.e. they are not showing as red on the system) 3 Measurement changed for Trust position to reflect standalone position rather than Peer SHA as previously. 70 6 Forward Planning For the future, meetings have been held with the directorates in order to determine their priorities and to provide an indication of the need for any of these priorities to be managed through this process. In order to provide high visibility of decision making, all projects that directorates would like to be taken forward by the PMO will be presented to the Programme Board and the decision made whether this is appropriate. Where there is agreement for the PMO approach to be used, this decision will be clearly recorded and communicated to the directorate. Likewise, any project that is ready to be closed will be approved and recorded by the Programme Board. In this way, there is a clear evidence trail of the rationale for opening and closing projects. 7 Project Risks Each project has a risk register to track the key risks to the delivery of the project. The Programme Board reviews the red risks on a monthly basis, using the PMO risk register. As of 12 November 2010, the highest risks were: • • Impact of the failure to achieve Risk Management Standards for maternity or general. Potential Impact of the PCT and Social Services economic constraints on the ability to facilitate complex discharges. Mitigating action is being taken to reduce these risks and the risk register is reviewed monthly by the Programme Board. 8 Monitor KPIs Performance against the KPIs agreed with Monitor for October is attached at Appendix 2. 9 Conclusion The discipline of the PMO approach to performance management continues to show tangible improvements in the quality of services provided by the Trust, with evidence to support this. The PMO has been operational for nearly one year and consideration is now being given to the future of the Office. As the discipline of the PMO is increasingly being embedded at directorate level, with many projects being delivered locally using this methodology, it is time to review the role and function of the PMO as it is currently configured and this will form the basis of a further report to the Board in December. 71 Appendix 1 MILESTONES Programme Management Office report on project progress Dashboard date: 15 November 2010 PMO reference Overall Risk (RAG) Previous Week A A Karen Fashanu Beth Smyth G G Karen Bates Develop and implement local guidelines for pneumonia (Monitoring) A A 1.01.02 Capacity management and discharge Discharge project: Surgery A 1.01.03 Capacity management and discharge Discharge project: Medicine A Priority area 1.04 Top 5 HSMR: Stroke Project Name Stroke Improvement Programme (Monitoring) Reduction in the incidence of Hospital Acquired PU, 2.13 of grade 2 and above Pressure Ulcer Management (Monitoring) 1.06 Top 5 HSMR: Pneumonia 1.01.04 Capacity management and discharge 1.05 Top 5 HSMR: COPD 1.07.01 Top 5 HSMR: Heart failure 1.08.1 Top 5 HSMR: AMI Discharges: Paediatrics A Project manager Deputy project manager RISKS - criteria and classification TBC in line with Trust process KEY PERFORMANCE INDICATORS This Week Cumulative YTD Planned no. of Actual Missed % Behind milestones Planned no. Actual Missed % Behind of milestones Performance against KPIs Last week No. of KPIs not met Previous % behind Planned no. of KPIs % Behind Rating (top) Mitigation actions set out ISSUES FOR PROGRAMME BOARD Risk RAG Exception Reporting Finance manager Information analyst Clinical lead Executive lead Duncan Stockwell Farhad Huwez Stephen Morgan 0 0 0% 88 0 0% 3 1 33% 33% Moderate risk Yes G KPIs regarding 90% of time on the stroke unit is 75% in September against a target of 90% Quarterly data. HSMR for July - 89.5 - HSMR update due 1.11.10. LOS is recorded as 24.9 against a target of 25 for September. (Monitoring) Linda Smart/Kirstie Metcalf/Cathy Plumley N/A N/A Diane Sarkar 0 0 0% 106 0 0% 3 0 0% 0% Moderate risk Yes G Workbook not been updated. LS advised that the project lead has been on annual leave and will feed in the data this week. (Monitoring) Andrea Holloway Sarah Lincoln Duncan Stockwell Johnson Samuel Stephen Morgan 0 0 0% 17 0 0% 2 1 50% 100% Moderate risk Yes G A Pam Charlesworth Deborah McCarthy / Nicki Abbott Jenny Davis Wendy English Mr Carew (Orth) & Mr Lafferty (Surg.) Mark Magrath 1 1 100% 17 1 6% 2 0 0% N/A High risk Yes R A Dawn Patience Sam Neville Wendy English Dr I Gupta Mark Magrath 1 1 100% 43 1 2% 2 0 0% 0% High risk Yes R . HSMR for August remains at 99.7. LOS being achieved with 13.9 against a target of 13 for September 2010. (Monitoring) Milestone due this week regarding stakeholder meeting to relaunch enhanced recovery programme. KPI regarding 95% of patients with EDD recorded on PAS is 98.2% w/c 1.11.10 and 80% of those with an EDD discharged on or before EDD is 93.2 w/c 1.11.10. Red risks within this workbook include financial constraints within the PCT, noro virus and flu outbreak and seasonal trauma. WORKBOOK NOT UPDATED One milestone not met re: continuing HC checklist training for 5 pilot wards . Average LOS by ward/directorate recorded as 8.66 for September. Number of discharges per week recorded as 260 for 11.10.10. Red risks within this workbook include financial constraints within the PCT, noro virus and flu outbreak and seasonal trauma.WORKBOOK NOT UPDATED G No Milestones due this week. DC has agreed to review the milestones in relation to what has been completed prior to her taking over the project. DC will also consider new actions for the workbook. DC hoping to engage Nursing staff prior to Consultant engagement in order to push this project forward. KPIs have been agreed, but trajectories are to be set regarding LOS for Wagtail and Puffin wards. LOS for Wagtail recorded as 1.7 for September and Puffin recorded as 3, trajectories to be added to the workbook. Project has been RAG rated as amber due to lack of visibility. WORKBOOK NOT UPDATED A Debbie Crisp Jane Thomas Sarah Lincoln Karen Stewart Karen Stewart Karen Stewart Karen Stewart Linda Smart Maureen Duncan Dr Sharief Mark Magrath 0 0 0% 28 0 0% 2 0 0% N/A Moderate risk Yes Embed COPD pathway G G Andrea Holloway Karen Stewart Duncan Stockwell Deepak Mukherjee Stephen Morgan 0 0 0% 60 0 0% 2 0 0% 0% Moderate risk Yes G Heart failure A A Danny McCormack Tina Faulkner Jenny Davis Anita Sutton Pat Phen Stephen Morgan 0 0 0% 12 0 0% 2 1 50% 50% Moderate risk Yes G AMI A A Tina Faulkner N/A Anita Sutton Pat Phen Stephen Morgan 0 0 0% 16 0 0% 2 1 50% 50% Moderate risk Yes G Jacqueline Smith No Milestones due this week. Achieving KPI regarding HSMR with 109.7 (against 110) recorded for August 2010. LOS has dropped for September with 6.8 against a target of 8. Compliance audit has now been completed which shows 60% compliance with the pathways. Dr Mukherjee will be circulating feedback at various Consultants meeting over the coming weeks. One KPI not being met regarding HSMR with 112.3 for August 2010 against a target of 100. No milestones due this week. Milestones on track. HSMR for August is recorded as 116.7 against a trajectory of 108. LOS is 7.1 for October 2010 against a target of 8.95. JS continues to audit all cases coded as AMI. Milestones outstanding with regards to the Named Paediatrician, HB has agreed to formalise a protocol for under 16 year olds, which will go to CD Board. HB to update KPI data re: number of Consultant Anaesthetists received advanced paediatric life support and number of A&E nursing staff trained in advanced paediatric life support or equivalent. WORKBOOK NOT UPDATED 1.10 Children's Services Review Children's Services Review Response and management of deteriorating 2.02 Response and management of deteriorating patient patient Ensuring compliance with Trusts standards for 2.05 DNAR Resuscitation 3.04 Top 5 HSMR: Other perinatal conditions. Perinatal Mortality A A Helen Boswell Tracey Glester Karen Stewart Maureen Duncan Ruth Taylor Diane Sarkar 2 2 100% 40 2 5% 2 2 100% 0% Moderate Risk Yes G Novi Ukpemo N/A Chris Welch Diane Sarkar 2 2 100% 81 3 4% 1 0 0% 0% Moderate risk Yes G N/A Mike Imana Stephen Morgan 2 0 0% 56 0 0% 2 0 0% 0% Moderate Yes G Milestone outstanding re: Publishing the patient safety strategy, fortnightly review of health records, contact Wendy English with regards to PAMS information. KPI being achieved with 100% recognition of the deteriorating patient against a target of 89%. WORKBOOK NOT UPDATED Milestones are on track. KPIs for October shows 81% of compliance with DNAR forms against a target of 90%, and 94% signed by a consultant against a target of 80%. Mr Ikomi Chris Welch 0 0 0% 38 0 0% 1 1 100% 100% Moderate Yes G Milestones on track. HSMR has increased again to 177.4 for August 2010 against a target of 100. Again this data continues to include the exceptionally high HSMR for September 2009 data. However CEMACH data does not currently show Perinatal Mortality as a significant outlier. G G Linda Smart Marie Nicholson/Cathy Plumley R G Rachel Johnson Rachel Crisp Jenny Davis G G Debbie Crisp Helen Boswell N/A PMO met with both HB and AF this week and had a very successful meeting. One milestones remains outstanding regarding extending Paediatric centre hours until midnight. However AF and HB have agreed to write a paper setting out that the original report around the extension to opening hours was completed very shortly after the unit opened and what is now required. It was also agreed that the Paediatric A&E unit does not need to be staffed by Paediatric Nurses alone. Agenda items in place for the next Paediatric Emergency care pathway meeting (Paeds and A&E) to include: - Registrar on shift supervising FY2s. - For the 1st month, no children are discharged without the FY2 checking with the Registrar. Flashcards for adult nurses supported by regular training programmes. - Resus Training to be arranged. 3.05 Children's Services Review 3.07.5 CQC Paediatric emergency care pathway NMC action plan A G A G Helen Boswell Lyn Cook Sally Brown Avril Archibald N/A TBC N/A Stephen Morgan Diane Sarkar 0 0 0 0 0% 0% 56 52 1 1 2% 0% 2 2 1 0 0% 0% 50% 0% Moderate Moderate risk Yes Yes G KPI not being achieved with regards to % of children being seen in the A&E/Paediatric unit with 71.6% against an increased trajectory of 80% (October). WORKBOOK NOT UPDATED G Milestones delay is regarding costings for the Midwifery lead unit which LC has still not received despite involvement of Jenny Galpin and Diane Sarkar. With regards to the Operational policy; the policy steering group was cancelled in October, so the next meeting will not take place until the end of November. LC will attempt to get this approved electronically. KPIs are being achieved. One milestone outstanding regarding agreeing reporting standards and trajectory. Both KPIs are being achieved. Last data update 4.10.10. Reports typed within one week not achieving with 70% No trajectory set. Trajectory not yet been agreed. RAG rating to be debated - Milestone remaining outstanding. KPI regarding reports typed within one week also has no trajectory, but target is set at 90. 3.09 Capacity management 2.14.01 CNST Radiology A G Risk Management Standards - General LEVEL 1 G G Risk Management Standards - General LEVEL 2 A A Risk Management Standards - General LEVEL 3 G G Michael Catling Paul Osborne N/A Dr Hails Mark Magrath 0 0 0% 23 1 4% 2 1 50% 0% 0 0 0% 53 0 0% 2 0 0% 100% Risk Managements Standards - Maternity 0 G G Yes High risk Yes G G Marie Nicholson Linda Smart. N/A N/A Andrea Saville 0 0 20 0 0% 1 0 0% N/A High risk Yes R Diane Sarkar 0 2.14.02 CNST Moderate risk 0 0 0 0 0 0 0 0% N/A Moderate Yes G Lynn Cook Helen Boswell N/A 4.02 Core business projects Productive theatres A A Marcie Tunbridge James Leek Jenny Davis 5.01 H&SE Manual Handling G G Stephanie Lawton Meera Nair N/A N/A Julie Plane Andrea Saville Diane Sarkar 5 0 0% 72 0 0% 2 0 0% 0% Moderate Yes G G Kevin Lafferty & Lyndsey Rylah & Bryony Lovett & Robert Carew Chris Welch 17 17 100% 298 20 7% 2 0 0% 100% Moderate Yes N/A Nigel Taylor 0 0 0% 12 0 0% 0 0 0% 0% Moderate Yes G Milestones and KPIs are complete for level 1 including all policies received. compliant and bookmarked. No milestones due this week for level 2. KPIs recorded as 51/51documents received for compliance checking. External auditor is completing a systematic review of information required for level 2. Bookmarking and hyperlinking will take place once this has been completed. Red risk still remains around Insufficient evidence of embedding at level 2 Milestones and KPIs for level 3 not being measured. Milestones are on track. Both KPIs are being achieved with 84% of health records compliant against a target of 75% in October 2010, and 100% of deadlines met with regards to CNST action plan on 1.11.10. Milestones outstanding regarding monthly news letter, review success of measures for each of the 3 components and new session start-up process to be agreed with Clinicians. KPI regarding the amount of operating time undertaken during a list is being achieved with 73.9% against a revised trajectory of 70% in w/c 1.11.10. Marcie has commenced population of utilisation of the number of lists which has been reported as 108 against a target of 118.75 for w/c 25.10.10 with 9 lists that were planned not to go ahead and 1 cancelled at short notice. WORKBOOK NOT UPDATED No milestones outstanding. No KPIs to be measured. All link co-ordinators have either already completed their training or are scheduled to complete by end of December 2010. Two milestones remain outstanding regarding finalising core shifts and determine annual leave entitlement. JM is awaiting OPD to finalise their core shifts and continues to chase them. TOIL balance for the Trust recorded as +835 w/c 1.11.10. Red risk remains regarding Bradford scoring and the absence interface. 4.01 Core business projects E-rostering A A Anthony Fitzgerald Jenny Mullin TBC Nigel Taylor 0 0 0% 19 2 11% 2 0 0% 0% High risk Yes R 72 Appendix 1 Milestones outstanding regarding discussion at capacity board and agreeing action plan to address system wide capacity problems. KPI regarding patients with a LOS over 44 days have increased with 21 w/c 8.11.10 against a trajectory of 40. This may often be the case as patients with a LOS over 30 days are not being looked. KPIs regarding Patients with a LOS over 100 days has reduced to w/c 8.11.10 against a target of 5. Targets have been amended in relation to the best of last years performance. Red risk remains relating to PCT and social services financial situation. 1.02 Capacity management and discharge Complex discharges A A A A Wendy Hurrell-SmithAndy Graham 6.01.1 QIPP New to follow up OPD project - Urology 6.01.2 QIPP New to follow up OPD project - General Surgery A A Lisa Want 6.01.3 QIPP New to follow up OPD project - Cardiology A A Yvonne Brierley 6.01.4 QIPP New to follow up OPD project - Maternity G A Lynn Cook N/A Lisa Want Mr Ravi/Mr Vohra Mark Magrath Mark Magrath 2 0 0 0 0% 0% 10 8 0 2 0% 25% 2 3 0 1 0% 33% 0% 0% Extreme Risk Moderate Yes Yes R R Two milestones have slipped this week re: complete milestones to reflect agreed actions (internal) and highlight to Emma Timpson actions required by Primary Care. KPI data is being populated but a trajectory needs to be agreed. Follow up ratio stands at 1:3.7 recorded w/c 8.11.10 (Aim to get to 1:2). Milestones being missed regarding external actions required to be discussed with Emma Timpson, reviewing the proceedure for outpatient appointments, review meetings with service managers to share findings and review of follow-up appointments 6 weeks in advance. KPIS being populated with the follow-up ratio currently recorded as 1:1.2 w/c 8.11.10 (Aim to get to 1:1) Mr Menon Mark Magrath 4 4 100% 11 6 55% 3 1 33% 0% Moderate Yes G Tina Faulkner Dr Phen Mark Magrath 2 1 100% 8 1 13% 3 1 33% 0% Extreme Risk Yes R Sue Grace Mr Ikomi Mark Magrath 1 1 100% 4 1 25% 3 0 0% 0% Moderate No G Milestones outstanding regarding implementing agreement of actions to be taken. KPI data is being populated. New to follow-up ratio recorded as 1:3.4 w/c 11.10.10. (aim to get to 1:1.45). Red risk regarding PCT support. Milestone slipped regarding determining actions to reduce F/up ratio. KPI data has been populated and the follow-up ratio recorded at 1:1.1 w/c 8.11.10 (Target of 1:2.2) 7 milestones outstanding this week re: Audit the cause of follow ups to determine clinical applicability, Identify if the care pathway is being followed by Consultants and Registrars and Identify the actions required to reduce to required levels and complete workbook with actions. Undertaking spot audits of 10 sets of notes (fortnightly) has also not been completed. KPI data is being populated and the follow up ration was recorded as 1:1.5 w/c 8.11.10 (Aim to get to 1:1.14) Red risks have been reviewied in light of the new BAF Risk Register and also down graded. 6.01.5 QIPP New to follow up OPD project - Gynaecology A A Jane Thomas 6.01.6 QIPP New to follow up OPD project - Oral Surgery A A Jo McCollum 6.01.7 QIPP New to follow up OPD project - Pain Management A A Carol Banks Mr Thakkur Mark Magrath 4 4 100% 15 7 47% 3 1 33% 0% Moderate Yes G Dawn Bramham Mark Magrath 2 1 50% 4 1 25% 3 1 33% N/A High risk To be added R Dawn Bramham Mark Magrath 2 2 100% 10 3 30% 3 0 0% N/A Moderate risk Yes R Two milestone slipped this week re: Complete workbook with additional actions and agreeing changes to clinic template and implement changes. KPIs data is being populated with a follow up ratio of 1:1.4 w/c 8.11.10 (Aim to get to 1:2.4) . Trajectory to be agreed. One milestone slipped this week re:to review appointments to determine reasons for follow-up. KPI data is being populated with follow up ratio recorded as 1:2.1 w/c 8.11.10 (Aim 1:1) 6.01.8 QIPP 3.03 Releasing Time to Care 1.11.03 A&E New to follow up OPD project - T&O A A Kim Saunders Nikki Abbott Releasing Time to Care A A Alison Griffiths Ganine Byford A &E working towards 2012 LD - Person centered pathways for better health outcomes 7.01.1 Quality Improvement 3.10 N/A N/A Julie Hickman Lokesh Narayanaswamy A A Lesley Roberts Anthony Fitgerald Karen Stewart Hayley Peters A A Shoenagh McKay Julie Hickman N/A N/A N/A N/A Karen Fashanu and Diane Baker TBC N/A Simple discharges: CTC (CLOSED) N/A N/A Tina Faulkner N/A N/A Andy Graham Anita Sutton Wendy HurrellSmith Jenny Davis Direct admissions (CLOSED) N/A End of Life Mark Magrath 1 1 100% 5 1 20% 3 1 33% N/A Extreme Risk Yes R One milestone slipped re agreeing protocols for follow-ups of non complex hip replacements.. KPI data is being populated with a follow up ratio of 1:1.6 for fracture clinic w/c 25.10.10 (Aim to get to 1:1.2) and T&O recorded as 1:1.6 w/c 8.11.10 (Aim to get to 1:1.2). Red risk remains regarding insufficient management capacity to deliver this project. To be reviewed once detail of workbook completed with actions. Clinical Lead is yet to be confirmed. Diane Sarkar 0 0 0% 0 0 0% 0 0 0% N/A Moderate Yes G PMO met with AG and discussed the best monitoring format for this project. It was agreed that the PMO approach is not flexible enough for this project and a steering group arrangement was considered. PMO debated this at the Programme Board on 5.11.10. Stephen Morgan Diane Sarkar 3 0 0% 7 0 0% 7 2 29% 0% Moderate Yes G 0 51 0 37 0% 73% 0 1289 0 54 0% 4% 0 74 0 17 0% 23% 0% TBC TBC TBC Milestones on track. KPI regarding average journey time through Majors in minutes (Median) is not being achieved with 221 minutes recorded w/c 1.11.10 against a target of 210. Also KPI with regards to average journey time through Minors in minutes (Median) is not being achieved with 187 minutes against 180 w/c 1.11.10. Workbook to be revised following SM meeting with the Project Manager for the EoE Project team. PMO agreed to meet again w/c 22.11.10. 0% 0% TBC TBC TBC PMO meetings to start shortly, following discussion with Dr Morgan. TBC TBC Anita Sutton Paul Kelly Mark Magrath 0 0 0% 17 0 0% 3 0 0% 0% Low Risk Yes G CLOSED N/A David Gertner Mark Magrath 0 0 0% 3 0 0% 1 0 0% 0% Moderate risk Yes G CLOSED CLOSED PROJECTS 1.01.01 Capacity management and discharge 1.03 Capacity management and discharge 1.09.02 A&E and MAU Nursing establishment on MAU (CLOSED) N/A N/A Kim Perry Lesley Roberts Karen Stewart Steven Lewis Elsir Osman Maggie Rogers 0 0 0% 27 0 0% 0 0 0% 0% Low risk Yes G CLOSED 1.09.01 A&E and MAU 3.02 A&E and MAU MAU education workstream (CLOSED) MAU medical leadership (CLOSED) N/A N/A N/A N/A Kim Perry Lesley Roberts Anthony Fitzgerald Karen Stewart Steven Lewis Maggie Rogers Stephen Morgan 0 0 0 0 0% 0% 12 46 0 0 0% 0% 2 3 0 0 0% 0% 100% 0% Low risk High risk Yes Yes G G CLOSED CLOSED 1.11.02 A&E and MAU A&E: RIE (CLOSED) Clinical data capture: generic clerking form (CLOSED) Primary Percutaneous Coronary Intervention (PPCI) (CLOSED) CQC Condition 4 - Assessment and Care Planning (CLOSED) N/A N/A Sarah Noon Lesley Roberts Karen Stewart Hayley Peters Elsir Osman Elsir Osman Lokesh Narayanaswamy Stephen Morgan 0 0 0% 70 0 0% 1 0 0% 100% Moderate risk Yes G CLOSED N/A N/A Kim Perry Anthony Fitzgerald Karen Stewart Duncan Stockwell Indi Gupta Stephen Morgan 0 0 0% 29 0 0% 2 0 0% 0% Moderate risk Yes G CLOSED N/A N/A Tina Faulkner Anita Sutton Jenny Davis Anita Sutton Stephen Morgan 0 0 0% 21 0 0% 4 0 0% 0% Moderate risk Yes G CLOSED N/A N/A Julie Hickman Linda Smart N/A Maggie Rogers 0 0 0% 13 0 0% 5 0 0% 0% High Risk Yes G CLOSED N/A N/A Pam Charlesworth Amanda Fife N/A Maggie Rogers 0 0 0% 21 0 0% 0 0 0% 0% High risk Yes G CLOSED N/A N/A Sarah Noon Lesley Roberts Karen Stewart TBC Lokesh Narayanaswamy Stephen Morgan 0 0 0% 11 0 0% 1 0 0% 0% Moderate risk Yes G CLOSED N/A N/A Linda Smart N/A Mark Magrath Nigel Taylor 0 0 0 0 0% 0% 75 14 0 0 0% 0% 2 0 0 0 0% 0% 0% 0% Moderate Moderate Yes Yes G G CLOSED CLOSED Novi Ukpemo N/A Linda Johnson Maggie Rogers 0 0 0% 27 0 0% 0 0 0% 0% Moderate risk Yes G CLOSED N/A N/A Adam SewellJones. Alan Whittle 0 0 0% 27 0 0% 0 0 0% 0% Moderate Yes G CLOSED Novi Ukpemo N/A N/A Chris Welch N/A Mark Magrath Nigel Taylor 0 0 0 0 0% 0% 79 3 0 0 0% 0% 1 0 0 0 0% 0% 0% 0% Moderate TBC Yes TBC G TBC CLOSED CLOSED N/A Duncan Stockwell Dr Yung Stephen Morgan 0 0 0% 14 0 0% 1 1 100% 100% Moderate Yes G CLOSED Novi Ukpemo N/A Diane Sarkar 0 0 0% 98 0 0% 2 0 0% 0% Moderate risk Yes G CLOSED Diane Sarkar Nigel Taylor 0 0 0 0 0% 0% 16 9 0 0 0% 0% 3 1 0 0 0% 0% 0% 0% Moderate risk Moderate risk Yes Yes G G CLOSED CLOSED Jenny Galpin Mark Magrath 0 0 0 0 0% 0% 23 23 0 0 0% 0% 3 1 0 0 0% 0% 0% 0% High risk Moderate risk Yes Yes G TBC CLOSED CLOSED 1.13 Clinical data capture and coding 1.08 Top 5 HSMR: AMI 3.07.4 CQC 2.07 Response and management of deteriorating patient PARS Service Review (CLOSED) Improved medical workforce for A&E 1.11.01 A&E and MAU (CLOSED) 3.01 Delivering Single Sex Accommodation 5.02 H&SE Delivering Single Sex Accommodation (CLOSED) Health & Safety Training (CLOSED) N/A N/A N/A N/A Marie Nicholson Stephanie Lawton Linda Smart & Cathy Plumley Meera Nair 1.18 Clinical data capture and coding Nursing documentation project (CLOSED) N/A N/A Julie Hickman Alison Griffiths CQC Non-compliance (CLOSED) N/A N/A Andrea Saville 1.12 Clinical data capture and coding 5.03 H&SE Coding Violence and Aggression (A&E) N/A N/A N/A N/A Ruth Taylor Eghosa Bazuaye Emma Timpson (Baz) Anthony Fitzgerald Sarah Noon 2.06 Reduce HSMR for Lung Cancer Lung Cancer N/A N/A Andrea Holloway 1.17 Learning disabilities Learning disabilities N/A N/A 3.07.1 CQC 3.07.2 CQC CQC Condition 1 - Training for acutely ill patients CQC Condition 2 - Staff Appraisals N/A N/A N/A N/A Shoenagh MacKay Julie Hickman Pam Charlesworth/Julie Hickman Linda Smart Stephanie Lawton Meera Nair 3.07.3 CQC 3.06 Capacity management and discharge CQC Condition 3 - Legionella Enabling capacity in MEC N/A N/A N/A N/A Rob Speight Simon Myles Anthony Fitzgerald 3.07.6 CQC Sarah Lincoln Hayley Peters Paul Kelly Julie Hickman N/A N/A N/A Dr Gertner KEY Closed projects Monitoring Pipeline or suspended 73 Appendix 2 Proposed Key Performance Indicators (KPIs) for Basildon & Thurrock University Hospitals NHS Foundation Trust Date: Metric Area of ToA ref no. breach 1 HSMR/Pathway Improvement 18‐Oct‐10 Objective Achieve an annual rebased HSMR index of less than 100. Objective Leads (Exec/Operational) Medical Director/Associate Medical Director Risk rating 8 Key Performance Indicator Dr Foster 12 month rolling average (basket of 56 HRGs) against index in place at the time of reporting Apr‐10 Actual 2 Hygiene Code Maintain average environmental cleanliness scores Director of Estates and at or above 95% in clinical areas identified as high and Facilities/ Facilities 98% in clinical areas identified as very high risk in the Manager NPSA national specifications for cleanliness with individual scores only falling below 93% for high and 96% for very high on a limited number of occasions in accordance with the agreed trajectory. This includes each theatre, ward & critical care area as well as A&E, maternity and pharmacy. Any area scoring less than 93% and 96% respectively to have an action plan to address areas of concern. 10 Provide evidence to the CQC of successful delivery Chief Executive/ against agreed action plans to allow for the removal Corporate Secretary of all conditions of registration. 5 Trajectory Number of occasions where high(H) or very high(VH) risk areas score below 93% and 96% respectively against the cleaning services elements in the national specifications for cleanliness . This is measured by regular ward/dept level monitoring reports. Actual Trajectory 3 CQC Registration 5 6 7 Children’s Services 75% of children attending A&E are treated in the designated Paediatric A&E unit Children’s Services Maintain high level (90% satisfaction) of Patient Experience in Children's A&E from Jan 2010 Governance 8 Director of Operations and Service Development/ GM, Medicine and Emergency care 9 Director of Nursing/ GM, Medicine and Emergency care 6 To achieve and maintain a governance risk rating of Chief Executive/ green, as set out within the Compliance Framework Associate Director of Operations (2010/11). 8 Deliver all actions agreed following the PwC Corporate governance review in line with timescales contained Secretary/Chief in the action plan Executive 4 Sep‐10 Oct‐10 Nov‐10 Dec‐10 Jan‐11 Feb‐11 97.7 Mar 2010 data 104.4 Apr 2010 data 98.3 103.4 May 99.9 Jun Jul 2010 data 2010 data 2010 data 97.4 Aug 2010 data Sep 2010 data Oct 2010 data Nov 2010 data 106 103 99 105 101 98 97 96 95 94 93 H ‐ 0 VH ‐ 2 H ‐ 0 VH ‐ 2 H ‐ 1 VH ‐ 3 H ‐ 0 VH ‐ 0 H ‐ 0 VH ‐ 0 H ‐ 0 VH ‐ 0 H ‐ 1 VH ‐ 0 H ‐ 2 VH ‐ 13 H ‐ 2 VH ‐ 13 H ‐ 2 VH ‐ 12 H ‐ 2 VH ‐ 11 H ‐ 2 VH ‐ 10 H ‐ 2 VH ‐ 10 H ‐ 2 VH ‐ 10 H ‐ 2 VH ‐ 10 H ‐ 2 VH ‐ 10 H ‐ 2 VH ‐ 10 H ‐ 2 VH ‐ 10 Agreement with CQC to Completed Completed extend to for condition for condition 15th September 1 2 Submitted Completed Condition 4 and 5 applications to vary condition submitted. Relevant staff Application to Application to Training vary vary trained to needs condition 1 condition 3 recognise analysis completed for deteriorating submitted. submitted. detriorating patient. Application to patient vary condition 2 submitted. Mar‐11 Comments The changes in the 12 month rolling average trajectory is driven by the net impact of each new months performance and the removal of month 13. Other measures of mortality continue to be reviewed including crude death rate and deaths as percentage of discharges. Work is continuing Dec 2010 to focus on both clinical quality and coding improvements. The impact of coding improvements data can be applied retrospectively and therefore previously reported figures can still be improved upon. Detailed work has been undertaken with Dr Foster and notes are constantly reviewed. Note: The trajectory increase has changed for data from Apr 2010 as the Dr Foster rebase has now taken place (previously anticipated in Oct 2010) 92 Regular inspections undertaken to ensure contract standard is being delivered. The NPSA states that "there are no national targets within these specifications, however, good practice would suggest that individual hospitals/trusts set their own aims. These should be realistic, achievable, challenging and regularly reviewed to ensure they contribute to an ethos of continuing improvement. Weekly monitoring of scores for all areas is undertaken by the executive team. This is considered at executive team meetings and through weekly ward/dept level scores being shared with the team. Exception reports and actions to address areas below this will be monitored by the Board. The requirement for an action plan where performance falls below 93% will ensure any areas of concern are addressed promptly if not already done so locally. Whilst the aim for these areas is 100% compliance, the threshold reflects the range of measures scored in each area and the practical challenge of delivering a perfect environment 100% of the time e.g. if the inspection takes place in a bathroom as a patient leaves it following use. H ‐ 2 VH ‐ 10 Registration achieved with 5 conditions from April 1 2010. 4 conditions now removed. Confirmation received that final condition being removed following unannounced visit. Completed for condition 3 NMC action plan complete. Actual 11 12 12 14 14 14 14 Internal training courses only provided twice per year, due to the need to use a faculty including external instructors . All staff will be trained within deadline; trajectory and targets have been set to deliver the standards included with the National Service Framework for Children. The qualification lasts for 3 years and any new staff will be picked up as part of the ongoing programme. Training of all consultants will now be achieved by Jan 2011 due to timing of training course. The Resuscitation Training Team actively seek vacant places on other organisation's training programmes. These are being utilised if available to achieve the objective earlier in 2010. Trajectory 9 12 12 13 13 13 13 13 16 16 16 16 % of children attending A&E using the Paediatric A&E unit Actual 69% 67% 67% 66% 67% 70% 68% Trajectory 65% 65% 65% 70% 70% 70% 75% 75% 75% 75% 75% 75% Actual 94% 91% 90% 90% 92% 98% 92% Trajectory 90% 90% 90% 90% 90% 90% 90% The increased opening hours of the unit planned for July will now happen in September due to the inability to recruit appropriate staff to ensure a robust rota, therefore performance will be behind trajectory but is still expected to deliver the target. As highlighted in July, it has been agreed with the A&E department to amend the metric to increase from 0‐15 years to 0‐16 years. This supports the operating arrangements of the department but reduces the target to 75%. Parallel data for this year supports the 5% reduction to target. The 25% not attending will include those children not deemed appropriate (e.g. due to seriousness of injuries and other factors) as well as those attending during the night and these categories increase when including 16 year olds. Unit opened end of Nov 2009. Satisfaction data captured from Jan 2010. Questionnaires based on a "yes/no" response to reflect positive and negative experience. An overall score of 90% indicates that 90% of answers to a standard 5 questions were positive. The target of 90% is in line with the stretch target the Board has agreed for satisfaction levels across the organisation. 5 questions for children and 5 for accompanying adults have been set and are being piloted. Responses will be asked of all children (where appropriate) and accompanying adults attending the paediatric unit. Additional qualititive data is also being collected and improvements have been made as a result. Percentage positive response score against 5 yes/no patient experience questions. 90% 90% 90% 90% 90% It is acknowledged that the Trust will be rated red for governance until Monitor deem otherwise and so the metrics are based on the points system within the compliance framework. The points from June are against the updated Compliance Framework. Monitor validated self‐certified service performance score 2.3 forecast 1.5 forecast 1 2.3 (Amber‐Red) Trajectory Governance Aug‐10 Staff undertaking training identified in needs assessment (cumulative) Actual 8 Jul‐10 100.2 Feb 2010 data Trajectory Medical Children’s Services All 16 Consultant Anaesthetists who work with children to receive Advanced Paediatric Life Support Director/Associate Medical Director training by Dec 2010 (and maintain certification through re‐training every 3 years) as agreed with the Healthcare Commission, 12 of whom will be trained by May 2010. Jun‐10 102.9 Jan 2010 data Achievement against milestones identified in detailed plan. Actual 4 May‐10 1 forecast 1 forecast 1 forecast 0 forecast <1.9 (Amber‐Green) <1.9 (Amber‐Green) <1.9 (Amber‐Green) The review carried out by PwC in Q4 2009/10 provided 35 recommendations for improvement. Against these recommendations the Trust agreed 67 actions, with completion dates, which were agreed with PwC. Following the follow‐up review in July 2010, additional actions have been developed but the KPI here rermains against the original plan. Number of actions delivered Actual 31 44 60 Trajectory 33 43 60 61 and review completed PwC to conduct review of progress 61 62 63 64 61 64 64 74 64 66 66 66 67 18/11/2010 Appendix 2 Metric Area of ToA ref no. breach 9 A&E Leadership 10 11 Capacity Management Learning Disabilities (LD) Objective 75% Percentage of patients referred to specialty doctor in 2 hours or less where appropriate Eliminate the use of escalation beds (day‐care facilities used by inpatients due to inpatient bed unavailability) by Apr 2010. Objective Leads Risk (Exec/Operational) rating 12 Director of Operations and Service Development/ GM, Medicine and Emergency care Director of Operations and Service Development/ Associate Director of Operations LD specialist nurse/ Ensure all patients with LD admitted as inpatients Director of Nursing have an LD assessment completed (as part of healthcare record) within 24 hours of admission and care plans are in place where appropriate 16 Key Performance Indicator % of appropriate patients referred to specialty doctors within 2 hours Apr‐10 Jun‐10 Jul‐10 Aug‐10 Sep‐10 Oct‐10 Actual 40% 40% 42% 39% 42% 36% 37% Trajectory 40% 40% 45% 50% 60% 65% 75% Nov‐10 75% Dec‐10 75% Jan‐11 75% Feb‐11 75% Mar‐11 Comments The Trust is delivering the 4 hour A&E target, however continued improvement in this domain will further improve performance and reduce overall time spent within the department. A change in process has been agreed and will be implemented an arrival of new middle grade doctors to improve performance in this area. An improvement event has been undertaken and a new process was piloted in Sep with the target expected to be achieved in Oct. Unfortunately the commencement of middle grades has not happened in line with the plan when the trajectory was first agreed owing to visa / certification issues. However the recruitment to establishment is now almost complete with staff scheduled for commencement Oct/Nov. 75% Average number of escalation beds used per day Actual 5 May‐10 Trajectory % of inpatients with LD having an full LD assessment completed (as part of healthcare record) and care plans in place as appropriate within Actual 24 hours of admission as reviewed by the LD specialist nurse. Trajectory 8 4.5 2.5 0.8 1.1 3.7 5.2 8 4 0 0 0 0 0 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% One ward currently closed for refurbishment has now re‐opened and the decant ward is available from 15th Nov 2010. NHS SW Essex closed 17 community beds during September. Financial pressure on both the PCT and Social Services increases the risk around this metric. Additional improvements to internal discharge processes are being implemented to mitigate this. 0 0 0 0 0 The LD specialist assessment was introduced during 2009. The LD specialist nurse reviews all new admissions to the hospital and the assessment carried out by the clinicians includes all issues included within the rule 43a letter issued by the coroner to the Trust in Jul 2009. Full assessment includes: All risk assessments completed within 6 hours, admission assessment of condition within one hour, consultation of preferences and special requirements with carers within 24 hours. Delivery against any specific care plans is part of the Principles of Care monthly audit programme and is reported to the Board monthly. 100% 100% 100% 100% 100% 75 18/11/2010 This page is left blank intentionally 76 BOARD OF DIRECTORS PART 1 MEETING 24 NOVEMBER 2010 AGENDA ITEM: (2) 7 ITEMS CONSIDERED BY THE BOARD OF CLINICAL DIRECTORS SINCE THE LAST BOARD OF DIRECTORS MEETING REPORT OF THE CHIEF EXECUTIVE Performance Report* The Board considered the Performance Report for September 2010. Financial Recovery Plan The Board considered the report which proposed a number of actions to return the Trust’s financial position to a forecast surplus. Payment by Results Briefing Paper 2011/12 The Board noted the report which provided detail of the proposed changes to the payment by results regime for the 2011/12 financial year. Guidelines for the Prevention and Management of Venous Thromboembolism The Board considered the report which presented the new Trust Guideline for the prevention and management of Venous Thromboembolism, which had been formulated to ensure compliance with NHSLA risk management standards. Infection Control The Board received an update from the Director of Infection Prevention and Control who advised the Board of the requirements to have in place a documented process for infection control to satisfy the requirements of NHSLA, level 2. Risk Management Standards. The Delivery of Adult Physiotherapy and Occupational Therapy Services The Board noted that Physiotherapy and Occupational Therapy Services staff who worked within the hospital had transferred to Trust employment from 1st November 2010. Dates of Meetings 2011 The Board considered and agreed proposed dates for Board of Clinical Directors meeting for 2011. 1 77 Management Core Brief The Board agreed the Management Core Brief for cascade to all staff. Clinical Tutor Update The Board received an update in relation to Medical Education at the Trust Service Restriction Policy The Board received a presentation from Dr Andrea Atherton, Director of Public Health, NHS South West Essex, advising of the changes to the Service Restriction Policy, arising from the NHS South West Essex Turnaround Plan Summary Care Record Programme The Board received a presentation in relation to the benefits of introducing the Summary Care record at the Trust Care Quality Commission Mortality Outlier Alert The Board received the reports which provided information and the associated required actions relating to the mortality outlier alerts received from the Care Quality Commission (CQC) in respect of the HRG diagnosis groups:- Intestinal Obstruction without Hernia - Chronic Ulcer of Skin Updated Assessment of NHS South West Essex Turnaround Plan * The report advised on the Trust’s assessment and impact of the NHS South West Essex revised turnaround programme for 2010/11 Clinical Site Management Reconfiguration The Board agreed proposals to strengthen current arrangements for clinical site management, and improvements to the overall utilisation of inpatient capacity. Policies and Guidelines The Board approved the following reviewed and updated policies • External Visits Serious Incidents (SIs) The Board received a verbal update in relation to recent Serious Incidents, and agreed that Serious Incidents would feature as a standing item on Board Agenda. 2 78 PART 1 BOARD OF DIRECTORS MEETING DATE: 24 NOVEMBER 2010 AGENDA ITEM (3) 12 NOTIFICATION OF A PLANNED PROVIDER COMPLIANCE REVIEW BY THE CARE QUALITY COMMISSION REPORT OF THE CORPORATE SECRETARY Purpose On Tuesday 9 November 2010, the Trust received notification from the Care Quality Commission (CQC) of its intention to undertake a planned Provider Compliance Review in response to information received about the Trust. The purpose of this report is to inform the Board of Directors of the immediate actions taken and the process followed to provide the information requested by the CQC in the timeframes given. Composition of the Report No. of pages: No. of appendices: 2 0 Summary– key issues To support this review, the CQC has requested additional information on the 16 outcomes of the “Essential Standards of Quality and Safety” most directly related to the quality and safety of care. The Trust was required to return the information to the CQC by Wednesday 17 November 2010. This deadline was met. The outcomes to be reviewed are detailed in the attached letter from the CQC. Key points: 1 A strategic response team consisting of Executive Directors and members of the Programme Management Office and Compliance Unit was convened to determine the actions needed to confirm compliance with the essential standards. 2 Daily meetings were held to review progress and ensure that all actions agreed were taken. These meetings were noted using a trained loggist. 3 An initial review of Performance Accelerator was completed in order to determine the level of evidence currently available (the Directorates have been updating this information since September, for the 6 month report to the Board). For consistency, the Executive team members reviewed the same outcomes that they had initially reviewed at the time of registration. 4 A gap analysis was undertaken and meetings were scheduled on 12 and 13 November with the outcome leads in order to test the evidence and agree additional evidence requirements. 5 Additional evidence was requested and submitted both corporately and at Directorate level in the period 10 – 16 November 2010. 6 The reporting format (accessed directly from Performance Accelerator) lists every item of evidence on the system which enables the CQC to review the level of detail considered when determining compliance. The Trust can expect a full site visit as a result of this notification, although the timescale for this is not yet known. 79 Recommendation(s)/ Decision required The Board of Directors is requested to note the report. Key Risks and Board Assurance The Trust must maintain full compliance with the Essential Standards of Quality and Safety and ensure up to date evidence of compliance is available at any time. In order to provide on-going assurance to the Board of Directors, a quarterly review of compliance will be undertaken and the results presented to the Board of Directors. Implications Patient Safety and Patient Experience: the Trust is required to maintain compliance with the Essential Standards of Quality and Safety in order to provide health services. The focus of compliance is on the outcome of care for patients. Financial (efficiency, economy, effectiveness): The CQC is able to impose financial penalties for noncompliance. Equality and Diversity: To maintain registration the Trust is required to explain how it promotes equality, diversity and human rights. Legal: Registration is a legal requirement in order to provide health and social care in England. Communications/Reputation: Registration without conditions will significantly improve the Trust’s reputation. NHS Constitution: The Essential Standards of Quality and Safety support the pledges and rights in the NHS Constitution. Acronyms/ abbreviations used in the report (where not stated): None Author: Ruth Taylor Status: Deputy Programme Director Date: 17 November 2010 80 PART 1 BOARD OF DIRECTORS MEETING DATE: 24 NOVEMBER 2010 AGENDA ITEM (6)15 CQC REGISTRATION – PROGRESS WITH ACTION PLAN REPORT OF THE CORPORATE SECRETARY Purpose The purpose of this report is to inform the Board of Directors of progress with the action plans developed to ensure compliance with the conditions to the Trust’s registration. Composition of the Report No. of pages: No. of appendices: 2 0 Summary– key issues 1. On 1 April 2010, the Care Quality Commission (CQC) granted the Trust Registration subject to 5 conditions. Four of these have been removed subsequently by the CQC. 2. The final condition linked to compliance with the Health and Safety Executive Improvement Notice relating to control of legionella in the water systems was reviewed by the Health and Safety Executive on 14 September. The CQC conducted an unannounced visit on 28 September 2010 and the final report confirms that the Trust is complaint with Outcome 10 (Regulation 15) Safe and Suitable premises indicating that the condition has been removed. Recommendation(s)/ Decision required The Board of Directors is requested to note the report. Key Risks and Board Assurance The Trust must now maintain full compliance with the Essential Standards of Quality and Safety and ensure up to date evidence of compliance is available. Implications Patient Safety and Patient Experience: the Trust is required to maintain compliance with the Essential Standards of Quality and Safety in order to provide health services. The focus of compliance is on the outcome of care for patients. Financial (efficiency, economy, effectiveness): The CQC is able to impose financial penalties for noncompliance. Equality and Diversity: To maintain registration the Trust is required to explain how it promotes equality, diversity and human rights. Legal: Registration is a legal requirement in order to provide health and social care in England. Communications/Reputation: Registration without conditions will significantly improve the Trust’s 81 reputation and build confidence. NHS Constitution: The Essential Standards of Quality and Safety support the pledges and rights in the NHS Constitution. Acronyms/ abbreviations used in the report (where not stated): None Author: Andrea Saville Status: Corporate Secretary Date: 2 November 2010 82
Similar documents
Board of Directors - Basildon and Thurrock University Hospitals
Members of the Board of Directors Chairman Mr M Large Non Executive Directors Mrs J Gibson Mr R Holmes Mr J Kent Mr T Parks Mr P Sheldrake Ms H Sturgess Mr P Wardle Executive Directors Mr A R Whit...
More information